<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
    <channel>
        <title>Clinical Journal of Oncology Nursing via MedWorm.com</title>
        <description>MedWorm.com provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest items from the 'Clinical Journal of Oncology Nursing' source.</description>
        <link><![CDATA[http://www.medworm.com/rss/search.php?qu=Clinical+Journal+of+Oncology+Nursing&t=Clinical+Journal+of+Oncology+Nursing&s=Search&f=source]]></link>
        <lastBuildDate>Wed, 08 Feb 2012 21:54:34 +0100</lastBuildDate>
        <item>
            <title>Top 10 articles: what do they tell us?</title>
            <link>http://www.medworm.com/index.php?rid=5664933&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22297000%26dopt%3DAbstract</link>
            <description>Authors: Mayer DK
    Abstract
    The editorial boards for the Oncology Nursing Forum and Clinical Journal of Oncology Nursing (CJON) looked at what you were reading in the past year (Moore, 2012) (see Table 1), and the list of articles tells us that you are focused on topics that help you in your daily work as oncology nurses. Two of the 10 highly ranked articles focused on adherence to oral medication regimens, which has gained increasing importance as the U.S. Food and Drug Administration (FDA) approves more oral cancer treatments. In fact, four of the seven new drugs approved by the FDA from 2010 to 2011 were oral agents (Vogelzang &amp; Kris, 2011). However, at the same time, we faced unprecedented drug shortages, including more than 20 IV chemotherapy drugs that were in short supply...</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5664933</comments>
            <pubDate>Wed, 01 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5664933</guid>        </item>
        <item>
            <title>Partnership and empowerment program: a model for patient-centered, comprehensive, and cost-effective care.</title>
            <link>http://www.medworm.com/index.php?rid=5664932&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22297001%26dopt%3DAbstract</link>
            <description>Authors: Brown C, Bornstein E, Wilcox C
    Abstract
    The Partnership and Empowerment Program model offers a comprehensive, patient-centered, and cost-effective template for coordinating care for underinsured and uninsured patients with cancer. Attention to effective coordination, including use of internal and external resources, may result in decreased costs of care and improved patient compliance and health outcomes.
    PMID: 22297001 [PubMed - in process] (Source: Clinical Journal of Oncology Nursing)</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5664932</comments>
            <pubDate>Wed, 01 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5664932</guid>        </item>
        <item>
            <title>Using an evidence-based practice process to change child visitation guidelines.</title>
            <link>http://www.medworm.com/index.php?rid=5664931&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22297002%26dopt%3DAbstract</link>
            <description>Authors: Falk J, Wongsa S, Dang J, Comer L, Lobiondo-Wood G
    Abstract
    The multidimensional scope of nursing practice requires a nurse to provide not only physical and psychosocial interventions for patients, but also to support the family, particularly as the end of life approaches. One of the highest priorities for patients at the end of life is being able to spend time with the family members who are most important to them. In the case of a parent with young children, such visits can provide a sense of joy and peace that is important to the overall well-being of all.
    PMID: 22297002 [PubMed - in process] (Source: Clinical Journal of Oncology Nursing)</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5664931</comments>
            <pubDate>Wed, 01 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5664931</guid>        </item>
        <item>
            <title>Clinical trials and communicating safely.</title>
            <link>http://www.medworm.com/index.php?rid=5664930&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22297003%26dopt%3DAbstract</link>
            <description>Authors: Ermete R
    Abstract
    In the arena of clinical trials, patient safety is of the highest concern. Despite rules and regulations to protect participants, errors still occur. Deviations from standard practice, complexity, and unfamiliarity all may contribute to errors that occur in the research setting. Detailed and precise communication must exist between the research team and clinical staff to maintain patient safety and protocol integrity.
    PMID: 22297003 [PubMed - in process] (Source: Clinical Journal of Oncology Nursing)</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5664930</comments>
            <pubDate>Wed, 01 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5664930</guid>        </item>
        <item>
            <title>Using nurse navigation to improve timeliness of lung cancer care at a veterans hospital.</title>
            <link>http://www.medworm.com/index.php?rid=5664929&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22297004%26dopt%3DAbstract</link>
            <description>Authors: Hunnibell LS, Rose MG, Connery DM, Grens CE, Hampel JM, Rosa M, Vogel DC
    Abstract
    The Connecticut Veterans Affairs Healthcare System (CT-VAHCS) sought to improve the timeliness of lung cancer care by filling the new position of cancer care coordinator with an advanced practice nurse (APN) functioning as a nurse navigator. The multifaceted nature of diagnosing lung cancer and the barriers encountered by patients and families as they access the complex healthcare system contributed to substantial delays in diagnosing and treating this disease. Beginning in January 2007 when the cancer care coordinator was hired, she recorded data regarding timeliness and stage at diagnosis for all patients diagnosed with non-small cell lung cancer. CT-VAHCS created and modified several proce...</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5664929</comments>
            <pubDate>Wed, 01 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5664929</guid>        </item>
        <item>
            <title>Autoethnography: reflective journaling and meditation to cope with life-threatening breast cancer.</title>
            <link>http://www.medworm.com/index.php?rid=5664928&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22297005%26dopt%3DAbstract</link>
            <description>Authors: Sealy PA
    Abstract
    Autoethnography is a qualitative research approach whereby the researcher shares personal stories that relate to the broader cultural context. Living through breast cancer showed me how reflective journaling and meditation can help one to cope with locally advanced breast cancer. The purpose of this autoethnography is to assist nurses in gaining a greater understanding of the primary cultural implications of (a) unresolved emotional issues from the past complicating current treatment and recovery for locally advanced breast cancer, and that (b) reflective journaling and meditation can provide an opportunity to &quot;socially reconstruct&quot; past psychological injury. In this example of autoethnography, I reconstructed the past by re-experiencing childhood wounds ...</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5664928</comments>
            <pubDate>Wed, 01 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5664928</guid>        </item>
        <item>
            <title>Biofield therapies and cancer pain.</title>
            <link>http://www.medworm.com/index.php?rid=5664927&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22297006%26dopt%3DAbstract</link>
            <description>Authors: Anderson JG, Taylor AG
    Abstract
    The public and healthcare professionals have become increasingly aware and accepting of the benefit in physical, psychological, social, and spiritual support for patients with cancer. Patients with cancer often seek nonpharmacologic interventions to complement conventional care and decrease the pain associated with cancer and its treatment. Most often referred to as complementary and alternative medicine (CAM), these supportive therapies consist of a heterogeneous group of modalities used as adjuncts to allopathic health care. Biofield therapies are CAM modalities that involve the direction of healing energy through the hands to facilitate well-being by modifying the energy field of the body. This critical review of studies of biofield thera...</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5664927</comments>
            <pubDate>Wed, 01 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5664927</guid>        </item>
        <item>
            <title>Survey of Experiences of an E-Mentorship Program: Part II.</title>
            <link>http://www.medworm.com/index.php?rid=5664926&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22297007%26dopt%3DAbstract</link>
            <description>Authors: Faiman B, Miceli TS, Richards T, Tariman JD
    Abstract
    Nurse educators (NEs) are responsible for providing continuing education to nurses, who are expected to remain knowledgeble in the diagnosis and management strategies of a range of cancers. Remaining abreast of up-to-date information can be a challenge. Part I of the e-mentorship program was developed in 2009 to provide NEs with the latest updates and educational materials to enhance multiple myeloma (MM) nursing knowledge. The second phase was completed in January 2011. Faculty developed four modules: overview of MM, peripheral neuropathy, bone health, and overview of transplantation. Seventeen MM nurses were identified to participate as mentors and partner with 34 mentees. Mentees were trained through monographs, journ...</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5664926</comments>
            <pubDate>Wed, 01 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5664926</guid>        </item>
        <item>
            <title>Update on the management of neuroendocrine tumors: focus on somatostatin antitumor effects.</title>
            <link>http://www.medworm.com/index.php?rid=5664925&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22297008%26dopt%3DAbstract</link>
            <description>Authors: Gardner-Roehnelt NM
    Abstract
    Although neuroendocrine tumors (NETs) have been recognized as a family of complex malignancies since 1907, major progress has been made only in the past 20 years in understanding and managing the disease. The detection and reported incidence of NETs have increased fivefold since 1973, suggesting that the tumors may be more common than previously believed. NETs arise predominantly in the gastrointestinal tract but can occur in any tissue containing endocrine precursor cells and can secrete hormone peptides that exert clinical symptoms of flushing and diarrhea. With the introduction of the somatostatin analog (SSA) octreotide in 1987, symptom management of NETs improved by diminishing morbidities and mortality associated with carcinoid syndrome. ...</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5664925</comments>
            <pubDate>Wed, 01 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5664925</guid>        </item>
        <item>
            <title>What men say about surviving prostate cancer: complexities represented in a decade of comments.</title>
            <link>http://www.medworm.com/index.php?rid=5664924&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22297009%26dopt%3DAbstract</link>
            <description>Authors: Galbraith ME, Hays L, Tanner T
    Abstract
    The experience of men who have completed cancer treatment and transitioned into survivorship is not well understood; therefore, a qualitative, descriptive, narrative analysis was conducted with open-ended questions that participants responded to annually during the course of a 10-year period. The participants expressed that the experience was complex and three themes were identified: &quot;symptoms,&quot; &quot;can't go back,&quot; and &quot;needs.&quot; Time also emerged as an important concern. Participants indicated that sexual and physical symptoms impacted their entire life and that acknowledgment, information, and help from others were important to their recovery. Returning to baseline functioning was no longer possible; rather, a new normal now existed. Th...</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5664924</comments>
            <pubDate>Wed, 01 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5664924</guid>        </item>
        <item>
            <title>Native cancer navigation: the state of the science.</title>
            <link>http://www.medworm.com/index.php?rid=5664923&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22297010%26dopt%3DAbstract</link>
            <description>Authors: Eschiti V, Burhansstipanov L, Watanabe-Galloway S
    Abstract
    The purpose of this literature review is to determine the current state of the science for the effectiveness of patient navigation on improving outcomes of cancer care across the continuum among Native Americans. The research will help healthcare professionals ascertain potential evidence-based practice guidelines and gaps in knowledge, which may provide direction for future research. Data synthesis included the use of Native navigation for cancer care, which has been demonstrated in limited, nonrandomized studies to improve cancer knowledge, access to care, and quality of life for Native Americans. Those studies had limitations, including small sample size, self-report of outcome measures, and lack of randomizatio...</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5664923</comments>
            <pubDate>Wed, 01 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5664923</guid>        </item>
        <item>
            <title>Interventional radiology in oncology: clinical management of patients undergoing transarterial chemoembolization for hepatic malignancies.</title>
            <link>http://www.medworm.com/index.php?rid=5664922&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22297011%26dopt%3DAbstract</link>
            <description>Authors: Perez-Rojas E
    Abstract
    Interventional radiology procedures treat a variety of solid tumor malignancies. Transarterial chemoembolization (TACE) is a minimally invasive procedure performed under fluoroscopic guidance that is used in treatment of hepatic malignancies because of hepatocellular carcinoma or malignancy that has metastasized to the liver. Patients undergoing a TACE procedure may manifest postembolization symptoms such as fever, nausea, vomiting, and abdominal pain, which may persist after discharge. Patients need to be educated on the importance of compliance with prescribed medications, clinical symptoms to be expected, and signs of potential complications that need to be reported.
    PMID: 22297011 [PubMed - in process] (Source: Clinical Journal of Oncology Nu...</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5664922</comments>
            <pubDate>Wed, 01 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5664922</guid>        </item>
        <item>
            <title>Bortezomib-induced peripheral neuropathy in patients with multiple myeloma.</title>
            <link>http://www.medworm.com/index.php?rid=5664921&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22297012%26dopt%3DAbstract</link>
            <description>Authors: Berkowitz A, Walker S
    Abstract
    Bortezomib-induced peripheral neuropathy (BIPN) often is difficult to manage or reverse once it occurs. Treatment usually involves dose-reduction, interruption, or cessation of therapy, as no other interventions have been proven effective. Oncology nurses must be vigilant and recognize BIPN early to prevent patients from experiencing symptoms and complications that may interfere with their quality of life.
    PMID: 22297012 [PubMed - in process] (Source: Clinical Journal of Oncology Nursing)</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5664921</comments>
            <pubDate>Wed, 01 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5664921</guid>        </item>
        <item>
            <title>Using care plans to enhance care throughout the cancer survivorship trajectory.</title>
            <link>http://www.medworm.com/index.php?rid=5664920&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22297013%26dopt%3DAbstract</link>
            <description>Authors: Belansky H, Mahon SM
    Abstract
    The Oncology Nursing Society (ONS) recognizes the importance of cancer survivorship and has launched several initiatives focused on cancer care since 2008. Cancer survivors are those who have been diagnosed with cancer, from the time of diagnosis until death. Recognizing the pivotal role that oncology nurses play in helping patients and their families navigate all phases of the cancer continuum, ONS has partnered with Journey Forward in the development of a survivorship care plan builder.
    PMID: 22297013 [PubMed - in process] (Source: Clinical Journal of Oncology Nursing)</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5664920</comments>
            <pubDate>Wed, 01 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5664920</guid>        </item>
        <item>
            <title>Looking for hope and forgiveness.</title>
            <link>http://www.medworm.com/index.php?rid=5664919&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22297014%26dopt%3DAbstract</link>
            <description>Authors: Zahasky KM, Collier J
    Abstract
    Facing and owning up to my mistakes was something I learned as a child. In our house, if you told the truth and admitted what you had done wrong, there was no punishment. If you decided to run, hide, or lie, punishment was swift and non-negotiable, with no hope of early release or pardon for subsequent good behavior.
    PMID: 22297014 [PubMed - in process] (Source: Clinical Journal of Oncology Nursing)</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5664919</comments>
            <pubDate>Wed, 01 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5664919</guid>        </item>
        <item>
            <title>Meet the CJON Editorial Board and Publications Staff.</title>
            <link>http://www.medworm.com/index.php?rid=5664918&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22297015%26dopt%3DAbstract</link>
            <description>Authors: 
    Abstract
    The following oncology nurses comprise the Editorial Board of the Clinical Journal of Oncology Nursing (CJON) for 2012. They are involved in clinical care and support the mission of CJON, which is to provide practical information necessary to care for patients and their families across the cancer continuum and to develop publication skills in oncology nurses. Each associate editor is receptive to working with those interested in authoring columns. The associate editors welcome your comments, ideas, and suggestions for column topics. Contact information for the editors can be found at the end of each description.
    PMID: 22297015 [PubMed - in process] (Source: Clinical Journal of Oncology Nursing)</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5664918</comments>
            <pubDate>Wed, 01 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5664918</guid>        </item>
        <item>
            <title>Strategic patient education program to prevent catheter-related bloodstream infection.</title>
            <link>http://www.medworm.com/index.php?rid=5664917&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22297016%26dopt%3DAbstract</link>
            <description>This article presents the history and roles of the Infusion Therapy Team at the University of Texas MD Anderson Cancer Center in CVC care and describes an organized patient education program that plays a key part in the institution's strategy to reduce and prevent CRBSI. Institutional standard policies and procedures for patient care should be in compliance with guidelines of the Centers for Disease Control and Prevention and the Joint Commission before any patient educational initiative is implemented. Such standards will serve as a guide to set up, organize, and implement an effective program.
    PMID: 22297016 [PubMed - in process] (Source: Clinical Journal of Oncology Nursing)</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5664917</comments>
            <pubDate>Wed, 01 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5664917</guid>        </item>
        <item>
            <title>Developing an interprofessional care plan for an older adult woman with breast cancer: from multiple voices to a shared vision.</title>
            <link>http://www.medworm.com/index.php?rid=5664916&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22297017%26dopt%3DAbstract</link>
            <description>This article describes the development of an interprofessional care plan for an older adult woman with breast cancer. Two collaborative expert workshops were used; 15 clinical experts reviewed an online patient case and were asked to prepare a uniprofessional care plan. In workshop 1, participants worked from a draft interprofessional care plan, synthesized from the uniprofessional care plans by research associates, to arrive at consensus on an ideal interprofessional care plan. Using qualitative inductive content analysis of workshop transcripts, specific changes and overall key principles were identified and used to revise the draft plan. Based on these findings, a generalized interprofessional care plan/oncology model was developed. Revisions and proposed model were validated through co...</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5664916</comments>
            <pubDate>Wed, 01 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5664916</guid>        </item>
        <item>
            <title>A qualitative analysis of cancer-related fatigue in ambulatory oncology.</title>
            <link>http://www.medworm.com/index.php?rid=5664915&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22297018%26dopt%3DAbstract</link>
            <description>Authors: Borneman T, Piper BF, Koczywas M, Munevar CM, Sun V, Uman GC, Ferrell BR
    Abstract
    The purpose of this study was to describe patients' perceptions of the causes, relief, related symptoms, meaning, and suffering secondary to cancer-related fatigue (CRF). In total, 252 patients with breast, lung, colon, and prostate cancers were enrolled in a quasiexperimental study to test the effects of a clinical intervention on reducing barriers to symptom management in ambulatory care. Analysis of data reported in this article was derived from the Piper Fatigue Scale-Revised. Using qualitative research methods and content analysis, written statements related to the impact of CRF were coded using the following themes: patients' perceptions of CRF, causes, relief, related symptoms, meaning...</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5664915</comments>
            <pubDate>Wed, 01 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5664915</guid>        </item>
        <item>
            <title>The challenge of existential issues in acute care: nursing considerations for the patient with a new diagnosis of lung cancer.</title>
            <link>http://www.medworm.com/index.php?rid=5664914&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22297019%26dopt%3DAbstract</link>
            <description>Authors: Lehto RH
    Abstract
    A new diagnosis of lung cancer is a highly threatening experience that raises personally relevant existential issues and brings death-related thoughts and concerns to mind. Those issues can be very disturbing to patients, leading to distress and potentially to a lowered quality of life. The purpose of this article is to present to the practicing oncology nurse the types of existential and death-related concerns that patients with a new diagnosis of lung cancer may have. In addition, the article identifies practical strategies and resources for oncology nurses who can help patients accept and manage the normal but often distressing responses to a life-threatening diagnosis.
    PMID: 22297019 [PubMed - in process] (Source: Clinical Journal of Oncology Nurs...</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5664914</comments>
            <pubDate>Wed, 01 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5664914</guid>        </item>
        <item>
            <title>Do you know quality care when you see it?</title>
            <link>http://www.medworm.com/index.php?rid=5465966&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22119967%26dopt%3DAbstract</link>
            <description>Authors: Fessele K
    Abstract
    The mission of the Oncology Nursing Society (ONS) is to promote excellence in oncology nursing and quality cancer care, but have you ever considered how that mission comes to life in your daily practice? Just as it can be challenging to describe the essence of nursing practice beyond listing specific tasks we perform each day, it may be difficult to routinely identify high-quality care. Our time is often drawn to clearly problematic areas of clinical care. Although this always will be necessary, changes associated with healthcare reform, reimbursement, and accreditation efforts highlight the need to also demonstrate consistently good clinician performance and patient outcomes.
    PMID: 22119967 [PubMed - in process] (Source: Clinical Journal of Oncology...</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5465966</comments>
            <pubDate>Thu, 01 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5465966</guid>        </item>
        <item>
            <title>Oncology massage therapists need education and support.</title>
            <link>http://www.medworm.com/index.php?rid=5465965&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22119968%26dopt%3DAbstract</link>
            <description>Authors: Muirhead A
    Abstract
    Selection of letters to be published is the decision of the editor. For acceptance, letters must be signed. A letter can appear anonymously if requested by the author. All letters are subject to editing. A letter that questions, criticizes, or responds to a previously published Clinical Journal of Oncology Nursing article automatically will be sent to the author of that article for a reply. This type of collegial exchange is encouraged. Send letters to CJONEditor@ons.org.
    PMID: 22119968 [PubMed - in process] (Source: Clinical Journal of Oncology Nursing)</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5465965</comments>
            <pubDate>Thu, 01 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5465965</guid>        </item>
        <item>
            <title>Palliative sedation.</title>
            <link>http://www.medworm.com/index.php?rid=5465964&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22119969%26dopt%3DAbstract</link>
            <description>Authors: Lawson M
    Abstract
    The focus of palliative care is to relieve human suffering; however, about 90% of patients with advanced cancer will experience severe pain. Intolerable human suffering may be defined in the healthcare setting as symptoms that cannot be tolerated or endured for any length of time. If the patient is unable to communicate, the family or identified decision maker for the patient may decide when symptoms cannot be endured any longer. All dimensions (i.e., physical, psychological, social, emotional, and spiritual) of the symptom causing suffering must be evaluated.
    PMID: 22119969 [PubMed - in process] (Source: Clinical Journal of Oncology Nursing)</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5465964</comments>
            <pubDate>Thu, 01 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5465964</guid>        </item>
        <item>
            <title>Development of a radiation skin care protocol and algorithm using the iowa model of evidence-based practice.</title>
            <link>http://www.medworm.com/index.php?rid=5465963&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22119970%26dopt%3DAbstract</link>
            <description>This article describes the use of the Iowa Model of Evidence-Based Practice to Promote Quality Care as a framework to identify and validate current evidence. The resulting radiation therapy algorithm provided a succinct guideline for nurses to direct the prevention and management of skin damage secondary to radiation therapy, thus improving quality care.
    PMID: 22119970 [PubMed - in process] (Source: Clinical Journal of Oncology Nursing)</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5465963</comments>
            <pubDate>Thu, 01 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5465963</guid>        </item>
        <item>
            <title>Tumor lysis syndrome: prevention and detection to enhance patient safety.</title>
            <link>http://www.medworm.com/index.php?rid=5465962&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22119971%26dopt%3DAbstract</link>
            <description>Authors: Maloney K, Denno M
    Abstract
    Patient safety is at the forefront of health care and nursing practice. Oncology nurses strive to provide safe oncologic care in their management of cancer, treatments, and side effects. Oncologic emergencies such as tumor lysis syndrome (TLS), however, are serious complications of cancer and cancer treatment. TLS often is seen in hematologic malignancies, such as lymphomas and leukemias, that frequently occur in older adults. As the population in the United States continues to age, nurses must be prepared to manage oncologic emergencies in older adults. Understanding the risk factors and preventive strategies for TLS provides oncology nurses with a foundation for managing a serious treatment complication. Patients and their caregivers need to u...</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5465962</comments>
            <pubDate>Thu, 01 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5465962</guid>        </item>
        <item>
            <title>Putting evidence into practice.</title>
            <link>http://www.medworm.com/index.php?rid=5465961&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22119972%26dopt%3DAbstract</link>
            <description>Authors: Von Ah D, Jansen C, Allen DH, Schiavone RM, Wulff J
    Abstract
    Cognitive impairment is a clinically complex symptom commonly experienced by cancer survivors. Although research in this area has grown, many questions remain regarding underlying mechanisms, trajectory, and specific interventions nurses can offer patients to prevent, treat, and manage cognitive impairment effectively. As part of the Oncology Nursing Society (ONS) Putting Evidence Into Practice (PEP) initiative, a comprehensive examination of the current literature was conducted to identify effective interventions for cognitive impairment in cancer survivors. The studies were categorized into nonpharmacologic interventions, including complementary and alternative therapies and cognitive training, and pharmacologi...</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5465961</comments>
            <pubDate>Thu, 01 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5465961</guid>        </item>
        <item>
            <title>The Management of Anxiety and Knowledge of Serum CA-125 After an Ovarian Cancer Diagnosis.</title>
            <link>http://www.medworm.com/index.php?rid=5465960&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22119973%26dopt%3DAbstract</link>
            <description>This article describes the relationship among anxiety, distress, and serum CA-125 levels in women with ovarian cancer. Women's anxiety about monitoring their CA-125 levels during chemotherapy also is discussed. Data from a randomized trial including self-reported anxiety and emotional distress of women following surgery after a primary diagnosis of ovarian cancer, their recorded serum CA-125 levels, and knowledge about their CA-125 levels were analyzed. In the sample, 26 of 30 women had serum CA-125 levels above the normal range. At baseline, the sample had an elevated mean anxiety score and an elevated distress score. A moderate association was found between a high serum CA-125 level and a high anxiety score at baseline, but the finding was not statistically significant. A negative nonsig...</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5465960</comments>
            <pubDate>Thu, 01 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5465960</guid>        </item>
        <item>
            <title>Oncology clinical trials nursing.</title>
            <link>http://www.medworm.com/index.php?rid=5465959&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22119974%26dopt%3DAbstract</link>
            <description>This article describes the process used to develop core competencies for the novice CTN, presents the final core competencies, and offers examples of how those competencies might be used in practice.
    PMID: 22119974 [PubMed - in process] (Source: Clinical Journal of Oncology Nursing)</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5465959</comments>
            <pubDate>Thu, 01 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5465959</guid>        </item>
        <item>
            <title>Untreated peristomal skin complications among long-term colorectal cancer survivors with ostomies.</title>
            <link>http://www.medworm.com/index.php?rid=5465958&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22119975%26dopt%3DAbstract</link>
            <description>Authors: McMullen CK, Wasserman J, Altschuler A, Grant ML, Hornbrook MC, Liljestrand P, Briggs C, Krouse RS
    Abstract
    This ethnography of family caregiving explored why peristomal skin complications are common and undertreated among colorectal cancer survivors with intestinal ostomies. Data were collected through in-depth interviews with 31 cancer survivors and their family caregivers, fieldwork, structured assessments, and medical records review, and analyzed with qualitative theme and matrix analyses. Survivors who received help changing the skin barrier around their stoma had fewer obstacles to detection and treatment of peristomal skin complications. Half of the survivors received unpaid help with ostomy care, and all such help came from spouses. Married couples who collaborated...</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5465958</comments>
            <pubDate>Thu, 01 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5465958</guid>        </item>
        <item>
            <title>The complex dual diagnosis of diabetes and cancer.</title>
            <link>http://www.medworm.com/index.php?rid=5465957&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22119976%26dopt%3DAbstract</link>
            <description>Authors: Stevens C, Dinkel S, Catanzaro J
    Abstract
    Diabetes and cancer are two of the top three killers in the United States. As the number of people surviving cancer increases, more patients will be living with both cancer and diabetes. This integrative review of the literature will provide an overview of diabetes, cancer, and the complex interactions between the two. A literature search was conducted and three main areas were identified that warrant additional discussion: the relationship between glucocorticoids and hyperglycemia, glucose control in the management of diabetes in patients with cancer, and an increased risk of certain cancers with the comorbid condition of diabetes. The hope is that, through additional research, evidence-based practice guidelines can be developed t...</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5465957</comments>
            <pubDate>Thu, 01 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5465957</guid>        </item>
        <item>
            <title>Identification of Side Effects Associated With Intolerance to BCR-ABL Inhibitors in Patients With Chronic Myeloid Leukemia.</title>
            <link>http://www.medworm.com/index.php?rid=5465956&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22119977%26dopt%3DAbstract</link>
            <description>Authors: Rios MB, Ault P
    Abstract
    Clinical intolerance occurs when the toxicity of a medication outweighs its clinical benefit. Early recognition of clinical intolerance to BCR-ABL inhibitors used for chronic myeloid leukemia (CML) is important for maximizing patient benefit. In CML, most side effects associated with BCR-ABL inhibitor therapy are mild and easily managed, so recognizing, monitoring, and addressing serious side effects may ensure optimal outcome. However, a subset of patients will be intolerant to first-line imatinib. Patients who experience unresponsive grade 3 or any grade 4 nonhematologic side effects to imatinib may require discontinuation and switching to second-line therapies, such as dasatinib or nilotinib, after identification of intolerance. The most common ...</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5465956</comments>
            <pubDate>Thu, 01 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5465956</guid>        </item>
        <item>
            <title>Evaluating the self-care agency of patients receiving outpatient chemotherapy.</title>
            <link>http://www.medworm.com/index.php?rid=5465955&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22119978%26dopt%3DAbstract</link>
            <description>Authors: Kawasaki Y, Uchinuno A, Arao H, Kobayashi T, Otsuka N
    Abstract
    Dramatic advances have been made in cancer treatment in recent years, enabling patients to leave the hospital more quickly and stay home while still undergoing treatment. As a result, the percentage of outpatients has been on the rise. Healthcare providers engaged in actual outpatient treatment, however, spend so much energy implementing daily procedures safely that they have little time remaining to provide patient education or carry out any other systematic patient support programs. Although self-care generally is believed to be what people do to help themselves, differences exist between Western countries and Japan in the interpretation of self-care. In Japan, obtaining necessary support from the family and ...</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5465955</comments>
            <pubDate>Thu, 01 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5465955</guid>        </item>
        <item>
            <title>Nursing perspectives on fulvestrant for the treatment of postmenopausal women with metastatic breast cancer.</title>
            <link>http://www.medworm.com/index.php?rid=5465954&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22119979%26dopt%3DAbstract</link>
            <description>This article provides oncology nurses with the knowledge needed to educate patients on the use of fulvestrant, to effectively administer this medication, and to prevent and manage potential side effects.
    PMID: 22119979 [PubMed - in process] (Source: Clinical Journal of Oncology Nursing)</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5465954</comments>
            <pubDate>Thu, 01 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5465954</guid>        </item>
        <item>
            <title>Exercise guidelines for adults with cancer: a vital role in survivorship.</title>
            <link>http://www.medworm.com/index.php?rid=5465953&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22119980%26dopt%3DAbstract</link>
            <description>Authors: Jankowski CM, Matthews EE
    Abstract
    Cancer survivors face many challenges as a result of their cancer diagnosis and treatment, most importantly the maintenance of physical well-being. Nurses and other health professionals strive to address the needs of cancer survivors, including providing appropriate health-promotion information for a physically active lifestyle. Cancer survivors are at greater risk for recurrence and for developing second cancers because of treatment effects, unhealthy lifestyle behaviors, or risk factors that contributed to the first cancer. In light of those concerns, guide-lines aimed at understanding and preventing secondary disease, recurrence, and the late and long-term effects of treatment are essential.
    PMID: 22119980 [PubMed - in process] (So...</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5465953</comments>
            <pubDate>Thu, 01 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5465953</guid>        </item>
        <item>
            <title>Venous thromboembolism and gliomas: the need for increased vigilance.</title>
            <link>http://www.medworm.com/index.php?rid=5465952&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22119981%26dopt%3DAbstract</link>
            <description>This article presents a case study of a patient with VTE and offers suggestions for future research.
    PMID: 22119981 [PubMed - in process] (Source: Clinical Journal of Oncology Nursing)</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5465952</comments>
            <pubDate>Thu, 01 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5465952</guid>        </item>
        <item>
            <title>Lay health advisors: promoting cancer screening and reducing disparities.</title>
            <link>http://www.medworm.com/index.php?rid=5465951&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22119982%26dopt%3DAbstract</link>
            <description>This article discusses the benefits of using lay health advisors to increase cancer awareness and screening in African American, Vietnamese, and Hispanic women in the United States.
    PMID: 22119982 [PubMed - in process] (Source: Clinical Journal of Oncology Nursing)</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5465951</comments>
            <pubDate>Thu, 01 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5465951</guid>        </item>
        <item>
            <title>A win-win situation.</title>
            <link>http://www.medworm.com/index.php?rid=5465950&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22119983%26dopt%3DAbstract</link>
            <description>Authors: Walton AM
    Abstract
    I recently had &quot;a win&quot; at work and, thankfully, the patient I was caring for did too. The day was as full of surprises; I went in to work intending to provide direct patient care, but found that there were fewer patients than usual on the unit, and was given administrative time instead. Midway through the shift, a nurse entered my office and tearfully asked, &quot;Can you take my patients and approve a schedule swap for me for tomorrow? My mom is sick.&quot; I agreed and picked up her patients. I looked forward to those four hours. In her report, my colleague described her four patients as &quot;jolly,&quot; &quot;enjoying her day,&quot; &quot;very pleasant,&quot; and &quot;the best,&quot; respectively. How often do we use those words in patient reports? I was set up for a win.
    PMID: 22119983 [PubMe...</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5465950</comments>
            <pubDate>Thu, 01 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5465950</guid>        </item>
        <item>
            <title>Music Therapy for End-of-Life Care.</title>
            <link>http://www.medworm.com/index.php?rid=5465949&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22119984%26dopt%3DAbstract</link>
            <description>Authors: Whitehead P
    Abstract
    What are the effects of music therapy with standard care versus standard care alone or standard care combined with other therapies on psychological, physiologic, and social responses in end-of-life care?
    PMID: 22119984 [PubMed - in process] (Source: Clinical Journal of Oncology Nursing)</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5465949</comments>
            <pubDate>Thu, 01 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5465949</guid>        </item>
        <item>
            <title>Self-care strategies for the management of bowel symptoms following sphincter-saving surgery for rectal cancer.</title>
            <link>http://www.medworm.com/index.php?rid=5465948&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22119985%26dopt%3DAbstract</link>
            <description>Authors: Landers M, Savage E, McCarthy G, Fitzpatrick JJ
    Abstract
    The primary aim of this article is to identify the self-care strategies that patients use to manage bowel symptoms experienced following sphincter-saving surgery for rectal cancer. Comparisons will be made with self-care strategies used by patients to manage chronic fecal incontinence and the bowel symptoms associated with other chronic bowel diseases, such as irritable bowel syndrome and inflammatory bowel disease. Published studies and conceptual literature from 2000-2010 were the data sources. Three major themes emerged from the literature reflecting the self-care strategies used by patients to manage bowel symptoms: functional self-care strategies (e.g., taking medication), social activity-related self-care strat...</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5465948</comments>
            <pubDate>Thu, 01 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5465948</guid>        </item>
        <item>
            <title>Diet assessment methods.</title>
            <link>http://www.medworm.com/index.php?rid=5465947&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22119986%26dopt%3DAbstract</link>
            <description>Authors: Ralph JL, Von Ah D, Scheett AJ, Hoverson BS, Anderson CM
    Abstract
    Diet may play a significant role in cancer prevention, disease progression, and treatment tolerance. An in-depth search of the literature revealed limited information geared toward nurses about diet assessment methods used in research. The purpose of this review is to synthesize the evidence regarding diet assessment methods important in oncology studies. The method used varied based on the study size, duration, and research question. For example, studies focusing on mean nutrient intake of a group used a 24-hour dietary recall, estimated food diary or dietary record, or food frequency questionnaire. Studies investigating usual nutrient intake predominately used multiple 24-hour dietary recalls, dietary reco...</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5465947</comments>
            <pubDate>Thu, 01 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5465947</guid>        </item>
        <item>
            <title>Osteoporosis related to disease or therapy in patients with cancer.</title>
            <link>http://www.medworm.com/index.php?rid=5465946&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22119987%26dopt%3DAbstract</link>
            <description>Authors: Wickham R
    Abstract
    Osteoporosis is a major public health issue in the general population, particularly in postmenopausal women. Patients with cancer may not only be at risk for primary osteoporosis, but for secondary osteoporosis related to cancer therapies-particularly therapies that impair gonadal function, lead to loss of serum estrogen, and negatively affect bone turnover. Normal bone remodeling is influenced by the receptor activator for nuclear kappa-B ligand pathway, calcium, vitamin D, and other nutrition factors, as well as modifiable and nonmodifiable factors. Identifying which patients with cancer are at risk for bone mineral density loss is important and may include patients with breast or prostate cancer, some survivors of pediatric malignancies, and adults wi...</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5465946</comments>
            <pubDate>Thu, 01 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5465946</guid>        </item>
        <item>
            <title>Many oncology nurses face the typology of illness journeys.</title>
            <link>http://www.medworm.com/index.php?rid=5364222&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22034675%26dopt%3DAbstract</link>
            <description>Authors: Carroll SA
    PMID: 22034675 [PubMed - in process] (Source: Clinical Journal of Oncology Nursing)</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5364222</comments>
            <pubDate>Sat, 01 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5364222</guid>        </item>
        <item>
            <title>Who cares for family caregivers of patients with cancer?</title>
            <link>http://www.medworm.com/index.php?rid=5269317&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21951730%26dopt%3DAbstract</link>
            <description>Authors: Given BA, Northouse L
    PMID: 21951730 [PubMed - in process] (Source: Clinical Journal of Oncology Nursing)</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5269317</comments>
            <pubDate>Sat, 01 Oct 2011 00:28:55 +0100</pubDate>
            <guid isPermaLink="false">5269317</guid>        </item>
        <item>
            <title>Letters to the editor.</title>
            <link>http://www.medworm.com/index.php?rid=5269316&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21951731%26dopt%3DAbstract</link>
            <description>Authors: Mayer DK
    Abstract
    Selection of letters to be published is the decision of the editor. For acceptance, letters must be signed. A letter can appear anonymously if requested by the author. All letters are subject to editing. A letter that questions, criticizes, or responds to a previously published Clinical Journal of Oncology Nursing article automatically will be sent to the author of that article for a reply. This type of collegial exchange is encouraged. Send letters to CJONEditor@ons.org.
    PMID: 21951731 [PubMed - in process] (Source: Clinical Journal of Oncology Nursing)</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5269316</comments>
            <pubDate>Sat, 01 Oct 2011 00:28:45 +0100</pubDate>
            <guid isPermaLink="false">5269316</guid>        </item>
        <item>
            <title>Calculating nutrition needs for a patient with head and neck cancer.</title>
            <link>http://www.medworm.com/index.php?rid=5269315&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21951732%26dopt%3DAbstract</link>
            <description>Authors: Ardilio S
    Abstract
    Patients with head and neck cancer often have distinct nutrition needs. The unique set of side effects of the disease process and treatment cause the patient to develop nutritional challenges. The challenges are complex to manage, often requiring supplemental feedings. Proper calculation of protein and caloric intake is necessary to meet the increased needs. Taking treatment and activity levels into account also is necessary when calculating nutrition requirements. Fluid balance can be delicate and requires attention, too. The dietitian determines the fluid needs of patients, using one of several calculations, and need is based on the patients' laboratory work and overall hydration status, which can be affected by inadequate fluid intake, diarrhea, and v...</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5269315</comments>
            <pubDate>Sat, 01 Oct 2011 00:28:35 +0100</pubDate>
            <guid isPermaLink="false">5269315</guid>        </item>
        <item>
            <title>Dosing done right: a review of common chemotherapy calculations.</title>
            <link>http://www.medworm.com/index.php?rid=5269314&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21951734%26dopt%3DAbstract</link>
            <description>This article will provide a review of evidence-based formulas and their rationale for use in dosing chemotherapy, case scenarios with practice calculations, and recommendations for safe verification of chemotherapy drug order accuracy.
    PMID: 21951734 [PubMed - in process] (Source: Clinical Journal of Oncology Nursing)</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5269314</comments>
            <pubDate>Sat, 01 Oct 2011 00:28:14 +0100</pubDate>
            <guid isPermaLink="false">5269314</guid>        </item>
        <item>
            <title>Putting evidence into practice.</title>
            <link>http://www.medworm.com/index.php?rid=5269313&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21951735%26dopt%3DAbstract</link>
            <description>This article presents information concerning radiodermatitis, summarizes the evidence-based review for its prevention and management, and identifies gaps in the literature, as well as opportunities for research, education, and practice.
    PMID: 21951735 [PubMed - in process] (Source: Clinical Journal of Oncology Nursing)</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5269313</comments>
            <pubDate>Sat, 01 Oct 2011 00:28:04 +0100</pubDate>
            <guid isPermaLink="false">5269313</guid>        </item>
        <item>
            <title>Preemptive management of dermatologic toxicities associated with epidermal growth factor receptor inhibitors.</title>
            <link>http://www.medworm.com/index.php?rid=5269312&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21951736%26dopt%3DAbstract</link>
            <description>Authors: Boucher J, Olson L, Piperdi B
    Abstract
    Epidermal growth factor receptor inhibitors (EGFRIs) are a treatment option for patients diagnosed with advanced-stage gastrointestinal, lung, and head and neck cancers. The most prevalent complications associated with EGFRIs are dermatologic toxicities, which may result in either disruption or discontinuation of treatment and adversely affect patients' quality of life. Nurses play a vital role in educating patients about EGFRI-related dermatologic toxicities; therefore, nurses must continue to educate themselves on the various aspects of EGFRI treatment. An overview of the EGF signaling pathway is provided, and dermatologic toxicities associated with EGFRI treatment are described. A review of several studies evaluating reactive skin ...</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5269312</comments>
            <pubDate>Sat, 01 Oct 2011 00:27:53 +0100</pubDate>
            <guid isPermaLink="false">5269312</guid>        </item>
        <item>
            <title>Nursing considerations with pazopanib therapy.</title>
            <link>http://www.medworm.com/index.php?rid=5269311&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21951737%26dopt%3DAbstract</link>
            <description>Authors: Bourdeanu L, Twardowski P, Pal SK
    Abstract
    The rapid evolution of targeted therapies has had a dramatic impact on multiple domains in oncology, particularly metastatic renal cell carcinoma (RCC). Four agents antagonizing vascular endothelial growth factor-mediated signaling have been approved for the treatment of metastatic RCC, including the monoclonal antibody bevacizumab and the small molecular inhibitors sunitinib, sorafenib, and pazopanib. Pazopanib was approved in 2009 for this disease on the basis of a phase III clinical trial demonstrating a superior progression-free survival compared to placebo in 435 patients with either treatment-naive or cytokine-refractory disease. The trial offered insight related to the toxicity profile associated with this agent. The most c...</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5269311</comments>
            <pubDate>Sat, 01 Oct 2011 00:27:42 +0100</pubDate>
            <guid isPermaLink="false">5269311</guid>        </item>
        <item>
            <title>The use of healing touch in integrative oncology.</title>
            <link>http://www.medworm.com/index.php?rid=5269310&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21951738%26dopt%3DAbstract</link>
            <description>This article describes the integrative use of the biofield therapy healing touch in conjunction with the chemoradiation received by patients with cervical cancer (stages IB1 to IVA) as reported in a 2010 research study. Findings indicated effects on the immune response and depression in healing touch recipients compared to patients receiving relaxation or standard care. Specifically, healing touch recipients demonstrated a minimal decrease in natural killer cell cytotoxicity over the course of treatment, whereas the cytotoxicity of patients receiving relaxation therapy and standard care declined sharply during radiation. Healing touch recipients also showed decreases in depressed mood compared to relaxation therapy and standard care recipients. The findings suggest that appropriate integra...</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5269310</comments>
            <pubDate>Sat, 01 Oct 2011 00:27:30 +0100</pubDate>
            <guid isPermaLink="false">5269310</guid>        </item>
        <item>
            <title>Nurses as patient advocates in oncology care.</title>
            <link>http://www.medworm.com/index.php?rid=5269309&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21951739%26dopt%3DAbstract</link>
            <description>This article will explore oncology nurses' patient advocacy activities and compare those activities with patient advocacy activities defined in an earlier study by the authors. Data were collected from 42 English-language peer-reviewed articles published from 2000-2010. Search terms used included cancer care and advocacy and oncology nursing and advocacy. According to the findings of the reviewed articles, oncology nurses promote the interests of their patients by analyzing patients' psychosocial and physical distress and care plans, particularly at the beginning of the illness trajectory. Oncology nurses also are instructed in the literature to educate patients about cancer management prior to the first treatment and during cancer management to promote informed consent, but not to analyze...</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5269309</comments>
            <pubDate>Sat, 01 Oct 2011 00:27:18 +0100</pubDate>
            <guid isPermaLink="false">5269309</guid>        </item>
        <item>
            <title>Practical management of imatinib in gastrointestinal stromal tumors.</title>
            <link>http://www.medworm.com/index.php?rid=5269308&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21951740%26dopt%3DAbstract</link>
            <description>Authors: Barnes T, Reinke D
    Abstract
    Gastrointestinal stromal tumors (GISTs) have an incidence of 7-15 occurrences per million people. Tyrosine kinase inhibitors (TKIs) have significantly improved clinical outcomes as part of multidisciplinary disease management. The authors will review developments in the management of GISTs, including diagnosis, risk stratification, prognosis, and treatment with imatinib. Imatinib is recommended for postsurgical adjuvant therapy and, where appropriate, neoadjuvant therapy. Clinical practice guidelines recommend first-line imatinib for metastatic and unresectable GISTs based on trials showing efficacy at the standard dose (400 mg per day) and at higher doses of 600-800 mg per day. Oncology nurses play a key role in patient management through (a) p...</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5269308</comments>
            <pubDate>Sat, 01 Oct 2011 00:27:07 +0100</pubDate>
            <guid isPermaLink="false">5269308</guid>        </item>
        <item>
            <title>Current practices in advance care planning.</title>
            <link>http://www.medworm.com/index.php?rid=5269307&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21951741%26dopt%3DAbstract</link>
            <description>Discussions regarding advance care planning (ACP) among patients with cancer and their physicians largely are not happening. Many patients with cancer, even those at the end of life (EOL), have not established an advance directive (AD). Lack of EOL discussions and receipt of aggressive care at the EOL have resulted in poor health outcomes for patients. In contrast, EOL discussions and early palliative care resulted in positive health outcomes for patients with cancer. The purpose of this review is to determine the current practices of ACP between healthcare providers and their patients in the United States and the use of ADs, particularly among patients with cancer. In addition, the authors offer recommendations for nurses and nurse practitioners on how to assist patients in ACP and the es...</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5269307</comments>
            <pubDate>Sat, 01 Oct 2011 00:26:56 +0100</pubDate>
            <guid isPermaLink="false">5269307</guid>        </item>
        <item>
            <title>The relationship between vitamin d and cancer.</title>
            <link>http://www.medworm.com/index.php?rid=5269306&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21951742%26dopt%3DAbstract</link>
            <description>Authors: Mitchell D
    Abstract
    Vitamin D, a fat-soluble vitamin naturally present in very few foods, is synthesized when ultraviolet rays from sunlight contact the skin. Research suggests that vitamin D insufficiency may result from lack of exposure to sunlight and ultraviolet-B radiation. Individuals from geographic areas of high latitude and low sunlight exposure may be at increased risk for vitamin D deficiency. Emerging evidence supports the protective role of vitamin D in the prevention of several cancers, including breast, colon, and prostate.
    PMID: 21951742 [PubMed - in process] (Source: Clinical Journal of Oncology Nursing)</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5269306</comments>
            <pubDate>Sat, 01 Oct 2011 00:26:46 +0100</pubDate>
            <guid isPermaLink="false">5269306</guid>        </item>
        <item>
            <title>Hypertrophic osteoarthropathy as a clinical manifestation of lung cancer.</title>
            <link>http://www.medworm.com/index.php?rid=5269305&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21951743%26dopt%3DAbstract</link>
            <description>This article presents a case study and describes symptom management options, including nonsteroidal anti-inflammatory agents, octreotide, and bisphosphonates.
    PMID: 21951743 [PubMed - in process] (Source: Clinical Journal of Oncology Nursing)</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5269305</comments>
            <pubDate>Sat, 01 Oct 2011 00:26:35 +0100</pubDate>
            <guid isPermaLink="false">5269305</guid>        </item>
        <item>
            <title>Evolution of an international collaboration: a unique experience across borders.</title>
            <link>http://www.medworm.com/index.php?rid=5269304&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21951744%26dopt%3DAbstract</link>
            <description>Authors: Vosit-Steller J, Morse AB, Mitrea N
    Abstract
    An international collaboration to support and mentor palliative care nurses was developed between two educational institutions in the New England region of the United States and the Hospice Casa Sperantei in Brasov, Romania. Through teleconferences, onsite visits, research, and shared publications, the collaboration continues to be a dynamic experience for the partners and students. The seven-year relationship has affected the Romanian nursing team by providing professional education and support, as well as validation of clinical practice.
    PMID: 21951744 [PubMed - in process] (Source: Clinical Journal of Oncology Nursing)</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5269304</comments>
            <pubDate>Sat, 01 Oct 2011 00:26:24 +0100</pubDate>
            <guid isPermaLink="false">5269304</guid>        </item>
        <item>
            <title>Fighting ovarian cancer one step at a time.</title>
            <link>http://www.medworm.com/index.php?rid=5269303&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21951745%26dopt%3DAbstract</link>
            <description>Authors: Sargent K
    PMID: 21951745 [PubMed - in process] (Source: Clinical Journal of Oncology Nursing)</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5269303</comments>
            <pubDate>Sat, 01 Oct 2011 00:26:14 +0100</pubDate>
            <guid isPermaLink="false">5269303</guid>        </item>
        <item>
            <title>Exercise interventions for upper-limb dysfunction caused by breast cancer treatment.</title>
            <link>http://www.medworm.com/index.php?rid=5269302&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21951746%26dopt%3DAbstract</link>
            <description>Authors: Hu C, Zhou L
    PMID: 21951746 [PubMed - in process] (Source: Clinical Journal of Oncology Nursing)</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5269302</comments>
            <pubDate>Sat, 01 Oct 2011 00:26:03 +0100</pubDate>
            <guid isPermaLink="false">5269302</guid>        </item>
        <item>
            <title>Development of tools and processes to improve treatment times in patients with febrile neutropenia.</title>
            <link>http://www.medworm.com/index.php?rid=5269301&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21951747%26dopt%3DAbstract</link>
            <description>This article describes a multidisciplinary best practice model with tools developed for achieving timely recognition of febrile neutropenia and a one-hour benchmark for antibiotic administration at any point of entry to the hospital. Collaboration between the cancer center and emergency department provided a vehicle for critically analyzing current practice and developing effective throughput pathways. The Neutropenic Fever Team process reduced throughput to an average of 53 minutes for patients with febrile neutropenia. Educational tools were developed and used to reinforce what patients and families can do to reduce the risk of life-threatening complications. Nurses are encouraged to implement this best practice model in different settings and to investigate how throughput processes and ...</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5269301</comments>
            <pubDate>Sat, 01 Oct 2011 00:25:53 +0100</pubDate>
            <guid isPermaLink="false">5269301</guid>        </item>
        <item>
            <title>Immunotherapy for advanced melanoma.</title>
            <link>http://www.medworm.com/index.php?rid=5269300&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21951748%26dopt%3DAbstract</link>
            <description>Authors: Roman RA
    Abstract
    The anticytotoxic T-lymphocyte antigen-4 (CTLA-4) monoclonal antibody ipilimumab was approved recently by the U.S. Food and Drug Administration for the treatment of patients with unresectable or metastatic melanoma. Anti-CTLA-4 treatment yields tumor responses or stable disease that may last months or years. Antitumor responses can occur within the first few weeks or even months after initiation of treatment, even as the disease appears to be progressing or new lesions are detected. Most side effects are immune related, consistent with the immune-based mechanism of action, and generally manageable with supportive measures and steroids. With anti-CTLA-4 therapy, patient response differs (both clinically and psychologically) to that generally observed with ...</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5269300</comments>
            <pubDate>Sat, 01 Oct 2011 00:25:43 +0100</pubDate>
            <guid isPermaLink="false">5269300</guid>        </item>
        <item>
            <title>Effects of oncology clinical nurse specialists' interventions on nursing-sensitive outcomes in South Korea.</title>
            <link>http://www.medworm.com/index.php?rid=5269299&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21951749%26dopt%3DAbstract</link>
            <description>This study compared outcomes, including pain, fatigue, anxiety, satisfaction, health-related quality of life (HRQOL), ease of access, and unexpected emergency room (ER) visits, for patients with cancer in South Korea who were cared for by an oncology clinical nurse specialist (CNS) with patients with cancer who were not. Self-report questionnaires and semistructured interviews were used to appraise the performance of oncology CNSs, and medical characteristics were obtained through chart review. CNS interventions were found to diminish some intensity scores of pain and fatigue, and to increase HRQOL, satisfaction with trustworthiness, and ease of access. No significant effects were observed on anxiety or unexpected ER visits. The current study provides evidence that oncology CNSs are effect...</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5269299</comments>
            <pubDate>Sat, 01 Oct 2011 00:25:33 +0100</pubDate>
            <guid isPermaLink="false">5269299</guid>        </item>
        <item>
            <title>Colorectal cancer family history assessment.</title>
            <link>http://www.medworm.com/index.php?rid=5269298&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21951750%26dopt%3DAbstract</link>
            <description>This article describes family history assessment for colorectal cancer in three outpatient gastroenterology units and examines gastroenterology unit nurses' knowledge and attitudes about family history assessments. Eighty-eight colonoscopy records were surveyed, and 16 RNs were interviewed. The medical record documentation was surveyed using a researcher-developed tool to identify type of cancer, age at disease onset, family relationship, and number of family members with cancer. Gastroenterology unit nurses were interviewed to assess knowledge and attitudes about family history assessment regarding colorectal cancer. Findings indicate that limited family history documentation was present in the medical record and that important age-at-disease-onset information was missing in 95% of patien...</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5269298</comments>
            <pubDate>Sat, 01 Oct 2011 00:25:23 +0100</pubDate>
            <guid isPermaLink="false">5269298</guid>        </item>
        <item>
            <title>Managing stomatitis in patients treated with Mammalian target of rapamycin inhibitors.</title>
            <link>http://www.medworm.com/index.php?rid=5269297&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21951751%26dopt%3DAbstract</link>
            <description>Authors: Pilotte AP, Hohos MB, Polson KM, Huftalen TM, Treister N
    Abstract
    Mammalian target of rapamycin (mTOR) inhibitors are a class of targeted cancer therapeutic agents with clinical benefit for multiple tumor types. Oral ulcerations are a common side effect of mTOR inhibitors; however, the clinical findings resemble aphthous stomatitis rather than the mucositis seen with chemotherapy. Consequently, the appearance of aphthous-like oral ulcerations has been referred to as mTOR inhibitor-associated stomatitis (mIAS). The severity of mIAS can be minimized by following common preventive steps and initiating treatment at the first sign of mouth discomfort, thereby reducing the likelihood of treatment discontinuation. mIAS can be managed through prophylactic measures, such as patient...</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5269297</comments>
            <pubDate>Sat, 01 Oct 2011 00:25:12 +0100</pubDate>
            <guid isPermaLink="false">5269297</guid>        </item>
        <item>
            <title>Cognitive-behavioral therapy for insomnia in patients with cancer.</title>
            <link>http://www.medworm.com/index.php?rid=5120722&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21810565%26dopt%3DAbstract</link>
            <description>This article attempts to demystify cognitive-behavioral therapy and provide nurses at different levels of practice a foundation from which to evaluate and potentially deliver this promising insomnia intervention.
    PMID: 21810565 [PubMed - in process] (Source: Clinical Journal of Oncology Nursing)</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5120722</comments>
            <pubDate>Sun, 31 Jul 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5120722</guid>        </item>
        <item>
            <title>Cancer is a team sport.</title>
            <link>http://www.medworm.com/index.php?rid=5120721&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21810566%26dopt%3DAbstract</link>
            <description>Authors: Campbell MK
    
    PMID: 21810566 [PubMed - in process] (Source: Clinical Journal of Oncology Nursing)</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5120721</comments>
            <pubDate>Sun, 31 Jul 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5120721</guid>        </item>
        <item>
            <title>Music therapy: a valuable adjunct in the oncology setting.</title>
            <link>http://www.medworm.com/index.php?rid=5120720&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21810567%26dopt%3DAbstract</link>
            <description>Authors: Mahon EM, Mahon SM
    Music therapy is the supervised and therapeutic use of music by a credentialed therapist to promote positive clinical outcomes. It can be a valuable form of complementary medicine in the oncology setting to decrease patient stress and anxiety, relieve pain and nausea, provide distraction, alleviate depression, and promote the expression of feelings. The music therapist assesses the patient and consults other members of the multidisciplinary team to create a therapeutic treatment plan. Music therapists design music sessions based on patients' needs and their intended therapeutic goals. Patients can participate actively or passively in individual or group sessions. Only a credentialed music therapist can provide safe and beneficial music therapy interventions....</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5120720</comments>
            <pubDate>Sun, 31 Jul 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5120720</guid>        </item>
        <item>
            <title>Performing breast cancer risk assessments in a community setting.</title>
            <link>http://www.medworm.com/index.php?rid=5120718&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21810568%26dopt%3DAbstract</link>
            <description>This article describes the implementation of a risk assessment program for women having screening mammography at a community center. The program used the National Cancer Institute's Breast Cancer Risk Assessment Tool to raise awareness in high-risk women. An evidence-based process is essential when implementing changes in clinical practice to overcome challenges and barriers.
    PMID: 21810568 [PubMed - in process] (Source: Clinical Journal of Oncology Nursing)</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5120718</comments>
            <pubDate>Sun, 31 Jul 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5120718</guid>        </item>
        <item>
            <title>Fall risk in adult inpatients with leukemia undergoing induction chemotherapy.</title>
            <link>http://www.medworm.com/index.php?rid=5120717&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21810569%26dopt%3DAbstract</link>
            <description>Authors: Filler K, Kelly DL, Lyon D
    Falls are a major concern for patients with acute myeloid leukemia who are admitted to the hospital for induction chemotherapy. Patients with cancer are at risk for rapidly changing health status and, therefore, need a different kind of fall surveillance than those in other inpatient units. Fall risk most likely will change throughout an inpatient's stay. Oncology nurses can start addressing this issue by reviewing the documented data of falls in this patient population.
    PMID: 21810569 [PubMed - in process] (Source: Clinical Journal of Oncology Nursing)</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5120717</comments>
            <pubDate>Sun, 31 Jul 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5120717</guid>        </item>
        <item>
            <title>Oncology pain and complementary therapy.</title>
            <link>http://www.medworm.com/index.php?rid=5120714&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21810570%26dopt%3DAbstract</link>
            <description>Authors: Running A, Turnbeaugh E
    Half of all patients with cancer experience some level of pain, so pain management is an important topic for oncology nurses. Pharmacologic measures traditionally are the primary intervention for bone, visceral, neuropathic, and procedural pain; however, many patients are turning to an integrative approach of Western and complementary therapies for pain and symptom management. The authors explored the current evidence concerning the effectiveness of complementary therapies in relation to cancer pain and symptom control.
    PMID: 21810570 [PubMed - in process] (Source: Clinical Journal of Oncology Nursing)</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5120714</comments>
            <pubDate>Sun, 31 Jul 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5120714</guid>        </item>
        <item>
            <title>Integrated community education model: breast health awareness to impact late-stage breast cancer.</title>
            <link>http://www.medworm.com/index.php?rid=5120711&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21810571%26dopt%3DAbstract</link>
            <description>Authors: Northington L, Martin T, Walker JT, Williams PR, Lofton SP, Cooper JR, Luther CH, Keller SD
    Race and ethnicity play roles in breast cancer mortality, particularly for African American women. As a result, a three-pronged integrated community education model (i.e., faith-based, community, and state agencies) was generated and tested in a medically underserved area with high mortality rates from breast cancer to increase participation in breast health education, provide early screening and detection practices, and provide access to annual mammograms and referral sources. The model provided three women with life-saving early diagnoses, in addition to providing potentially hundreds of women with a network of breast health, self-monitoring, and referral sources for future issues.
  ...</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5120711</comments>
            <pubDate>Sun, 31 Jul 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5120711</guid>        </item>
        <item>
            <title>Atypical clinical response patterns to ipilimumab.</title>
            <link>http://www.medworm.com/index.php?rid=5120670&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21810572%26dopt%3DAbstract</link>
            <description>This article presents cases of patients receiving ipilimumab in clinical trials along with a discussion of their significance and relevance to nursing practice. The patients showed different response patterns to ipilimumab and also had various typical immune-related adverse events (irAEs), which were managed successfully. The atypical response patterns produced by ipilimumab likely reflect its mechanism of action, which requires time for the immune system to mount an effective antitumor response. Meanwhile, lesions may appear to enlarge as a consequence of enhanced T-cell infiltration, although this may not necessarily be true disease progression. Patients receiving ipilimumab may respond very differently compared to how they might react to chemotherapy. Responses can take weeks or months ...</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5120670</comments>
            <pubDate>Sun, 31 Jul 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5120670</guid>        </item>
        <item>
            <title>Development of a teaching tool for women with a gynecologic malignancy undergoing minimally invasive robotic-assisted surgery.</title>
            <link>http://www.medworm.com/index.php?rid=5120669&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21810573%26dopt%3DAbstract</link>
            <description>Authors: Castiglia LL, Drummond N, Purden MA
    Women undergoing minimally invasive robotic-assisted surgery for a gynecologic malignancy have many questions and concerns related to the cancer diagnosis and surgery. The provision of information enhances coping with such illness-related challenges. A lack of print materials for these patients prompted the creation of a written teaching tool to improve informational support. A booklet was developed using guidelines for the design of effective patient education materials, including an iterative process of collaboration with healthcare providers and women who had undergone robotic-assisted surgery, as well as attention to readability. The 52-page booklet covers the trajectory of the woman's experience and includes the physical, psychosocial, ...</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5120669</comments>
            <pubDate>Sun, 31 Jul 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5120669</guid>        </item>
        <item>
            <title>Creating a palliative educational session for hematopoietic stem cell transplantation recipients at relapse.</title>
            <link>http://www.medworm.com/index.php?rid=5120668&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21810574%26dopt%3DAbstract</link>
            <description>This article will apply the End-of-Life Nursing Education Consortium content principles to tailor an education session in an advanced practice nursing research intervention after a relapse from HSCT. The components were a specific session devoted to relapse, family-focused education and assessment, and bereavement follow-up. The details of the three steps are discussed with application to four case studies, which describe the variety of scenarios that can occur and illustrate how a standard approach should be tailored for each situation. In addition, the actual teaching tools and forms used for the intervention are included.
    PMID: 21810574 [PubMed - in process] (Source: Clinical Journal of Oncology Nursing)</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5120668</comments>
            <pubDate>Sun, 31 Jul 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5120668</guid>        </item>
        <item>
            <title>Overview and Experience of a Nursing e-Mentorship Program.</title>
            <link>http://www.medworm.com/index.php?rid=5120667&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21810575%26dopt%3DAbstract</link>
            <description>Authors: Faiman B
    Little is known regarding the feasibility and efficacy of an online continuing education program for oncology nurses. The Multiple Myeloma Mentorship Program, a quality improvement project for the Institute for Medical Education and Research, was designed to meet the educational needs of oncology nurses caring for patients with multiple myeloma. Twenty-five expert nurses with expertise in multiple myeloma from 23 cancer centers in the United States partnered with 50 oncology nurses in an electronic format from July 2009 to January 2010. The purpose of the program was to educate oncology nurses about the latest treatments and strategies for optimal side-effect management for patients with multiple myeloma. Nurse mentees selected their preferred form of learning-webcast...</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5120667</comments>
            <pubDate>Sun, 31 Jul 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5120667</guid>        </item>
        <item>
            <title>Metastatic pancreatic cancer: what can nurses do?</title>
            <link>http://www.medworm.com/index.php?rid=5120666&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21810576%26dopt%3DAbstract</link>
            <description>Authors: Macintyre J
    The median survival of patients with metastatic pancreatic cancer is three to six months, making the diagnosis difficult to accept for patients, family, and healthcare providers. Therapeutic options are improving, but the treatment of advanced disease remains palliative. For oncology nurses, understanding the therapeutic and palliative options can provide these patients and their caregivers with additional information to make appropriate and individualized healthcare decisions.
    PMID: 21810576 [PubMed - in process] (Source: Clinical Journal of Oncology Nursing)</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5120666</comments>
            <pubDate>Sun, 31 Jul 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5120666</guid>        </item>
        <item>
            <title>Management of chronic graft-versus-host disease.</title>
            <link>http://www.medworm.com/index.php?rid=5120665&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21810577%26dopt%3DAbstract</link>
            <description>This article describes the ability of extracorporeal photopheresis therapy to exhibit a steroid-sparing effect, which can reduce long-term complications as a consequence of steroid treatment.
    PMID: 21810577 [PubMed - in process] (Source: Clinical Journal of Oncology Nursing)</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5120665</comments>
            <pubDate>Sun, 31 Jul 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5120665</guid>        </item>
        <item>
            <title>Administering chemotherapy in nononcology settings: a case study.</title>
            <link>http://www.medworm.com/index.php?rid=5120664&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21810578%26dopt%3DAbstract</link>
            <description>This article describes a case study and provides suggestions for planning in similar situations.
    PMID: 21810578 [PubMed - in process] (Source: Clinical Journal of Oncology Nursing)</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5120664</comments>
            <pubDate>Sun, 31 Jul 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5120664</guid>        </item>
        <item>
            <title>Experiences of a physician with neck cancer.</title>
            <link>http://www.medworm.com/index.php?rid=5120663&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21810579%26dopt%3DAbstract</link>
            <description>Authors: Brook I
    
    PMID: 21810579 [PubMed - in process] (Source: Clinical Journal of Oncology Nursing)</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5120663</comments>
            <pubDate>Sun, 31 Jul 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5120663</guid>        </item>
        <item>
            <title>Pharmacologic treatments for fatigue associated with palliative care.</title>
            <link>http://www.medworm.com/index.php?rid=5120662&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21810580%26dopt%3DAbstract</link>
            <description>Authors: Kirshbaum M
    
    PMID: 21810580 [PubMed - in process] (Source: Clinical Journal of Oncology Nursing)</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5120662</comments>
            <pubDate>Sun, 31 Jul 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5120662</guid>        </item>
        <item>
            <title>Progress made in myeloma research through multiple efforts.</title>
            <link>http://www.medworm.com/index.php?rid=5120661&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21816705%26dopt%3DAbstract</link>
            <description>Authors: Mayer DK
    
    PMID: 21816705 [PubMed - in process] (Source: Clinical Journal of Oncology Nursing)</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5120661</comments>
            <pubDate>Sun, 31 Jul 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5120661</guid>        </item>
        <item>
            <title>Survivorship care guidelines for patients living with multiple myeloma.</title>
            <link>http://www.medworm.com/index.php?rid=5120660&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21816706%26dopt%3DAbstract</link>
            <description>Authors: Bilotti E, Faiman BM, Richards TA, Tariman JD, Miceli TS, Rome SI, The International Myeloma Foundation Nurse Leadership Board 
    Novel therapies approved over the past decade for the management of multiple myeloma have contributed to improved overall survival in patients with newly diagnosed and relapsed disease. Nurses play a key role in educating, advocating for, and supporting patients throughout the continuum of care. Identifying potential and actual comorbid conditions associated directly with multiple myeloma and its treatment is important, as is confirming those that are patient specific so that prompt intervention can take place; therefore, the International Myeloma Foundation Nurse Leadership Board identified the most significant needs of patients diagnosed with multip...</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5120660</comments>
            <pubDate>Sun, 31 Jul 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5120660</guid>        </item>
        <item>
            <title>Maintaining bone health in patients with multiple myeloma.</title>
            <link>http://www.medworm.com/index.php?rid=5120659&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21816707%26dopt%3DAbstract</link>
            <description>Authors: Miceli TS, Colson K, Faiman BM, Miller K, Tariman JD, The International Myeloma Foundation Nurse Leadership Board 
    About 90% of individuals with multiple myeloma will develop osteolytic bone lesions from increased osteoclastic and decreased osteoblastic activity. Severe morbidities from pathologic fractures and other skeletal events can lead to poor circulation, blood clots, muscle wasting, compromised performance status, and overall poor survival. Supportive care targeting bone disease is an essential adjunct to antimyeloma therapy. In addition, the maintenance of bone health in patients with multiple myeloma can significantly improve quality of life. Oncology nurses and other healthcare providers play a central role in the management of bone disease and maintenance throughou...</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5120659</comments>
            <pubDate>Sun, 31 Jul 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5120659</guid>        </item>
        <item>
            <title>Routine health maintenance in patients living with multiple myeloma.</title>
            <link>http://www.medworm.com/index.php?rid=5120658&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21816708%26dopt%3DAbstract</link>
            <description>Authors: Bilotti E, Gleason CL, McNeill A, The International Myeloma Foundation Nurse Leadership Board 
    Patients diagnosed with multiple myeloma are living longer because of new therapeutic options. Helping patients with multiple myeloma maintain a good state of health from the time of diagnosis and throughout their therapy leads to better quality of life. However, patients with multiple myeloma are at risk for illnesses experienced by the general population and at additional risk for illnesses related to multiple myeloma and its treatment. Therefore, the International Myeloma Foundation Nurse Leadership Board (NLB) has developed practice recommendations to meet the particular needs of adult patients with multiple myeloma using evidence-based recommendations for screening and disease p...</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5120658</comments>
            <pubDate>Sun, 31 Jul 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5120658</guid>        </item>
        <item>
            <title>Mobility and safety in the multiple myeloma survivor.</title>
            <link>http://www.medworm.com/index.php?rid=5120657&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21816709%26dopt%3DAbstract</link>
            <description>Authors: Rome SI, Jenkins BS, Lilleby KE, The International Myeloma Foundation Nurse Leadership Board 
    As in many other cancers, survivorship of multiple myeloma involves handling treatment, recovery from therapeutic interventions, the effects of the disease, and ongoing therapies. Although mobility challenges vary among survivors of multiple myeloma, these patients have an increased risk of impaired mobility because of side effects of therapy and the pathology of the disease, as well as other factors (e.g., increasing age). Health maintenance increasingly is becoming a part of the cancer control continuum, and nurses have the opportunity to help survivors of multiple myeloma optimize their functional mobility and safety, thereby preserving quality of life. The purpose of these practic...</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5120657</comments>
            <pubDate>Sun, 31 Jul 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5120657</guid>        </item>
        <item>
            <title>Sexual dysfunction in multiple myeloma.</title>
            <link>http://www.medworm.com/index.php?rid=5120656&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21816710%26dopt%3DAbstract</link>
            <description>Authors: Richards TA, Bertolotti PA, Doss D, McCullagh EJ, The International Myeloma Foundation Nurse Leadership Board 
    The World Health Organization describes sexuality as a &quot;central aspect of being human throughout life and encompasses sex, gender identities and roles, sexual orientation, eroticism, pleasure, intimacy, and reproduction. Sexuality is influenced by the interaction of biological, psychological, social, economic, political, cultural, ethical, legal, historical, religious, and spiritual factors.&quot; Currently, no research has been conducted regarding sexual dysfunction in patients with multiple myeloma; therefore, information related to the assessment and evaluation of sexual dysfunction is gleaned from other malignancies and diseases. In this article, members of the Interna...</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5120656</comments>
            <pubDate>Sun, 31 Jul 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5120656</guid>        </item>
        <item>
            <title>Renal complications in multiple myeloma and related disorders.</title>
            <link>http://www.medworm.com/index.php?rid=5120655&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21816711%26dopt%3DAbstract</link>
            <description>Authors: Faiman BM, Mangan P, Spong J, Tariman JD, The International Myeloma Foundation Nurse Leadership Board 
    Kidney dysfunction is a common clinical feature of symptomatic multiple myeloma. Some degree of renal insufficiency or renal failure is present at diagnosis or will occur during the course of the disease and, if not reversed, will adversely affect overall survival and quality of life. Chronic insults to the kidneys from other illnesses, treatment, or multiple myeloma itself can further damage renal function and increase the risk for additional complications, such as anemia. Patients with multiple myeloma who have light chain (Bence Jones protein) proteinuria may experience renal failure or progress to end-stage renal disease (ESRD) and require dialysis because of light chain ...</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5120655</comments>
            <pubDate>Sun, 31 Jul 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5120655</guid>        </item>
        <item>
            <title>The need to be aware and beware of the genetic information nondiscrimination act.</title>
            <link>http://www.medworm.com/index.php?rid=4927913&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21624856%26dopt%3DAbstract</link>
            <description>Authors: Steck MB, Eggert JA
    Genetic advancements have presented numerous discrimination predicaments to individuals, the healthcare community, and legislators at state and federal levels. Oncology nurses should be knowledgeable about the Genetic Information Nondiscrimination Act of 2008 (GINA) and its applications to clinical practice. GINA is the first federal law passed to protect U.S. citizens with inherited disorders from being treated unfairly because of their genetic makeup. Understanding the legislation known as GINA, including how it modifies existing federal laws governing health insurance coverage and employment discrimination, can assist oncology nurses in providing important education and advocating for patients and their extended families. Federal agencies that govern and...</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4927913</comments>
            <pubDate>Tue, 31 May 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4927913</guid>        </item>
        <item>
            <title>Evidence-based practice: challenging what we think we know.</title>
            <link>http://www.medworm.com/index.php?rid=4927912&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21624857%26dopt%3DAbstract</link>
            <description>Authors: Mayer DK
    &quot;It isn't what we don't know that gives us trouble, it's what we know that ain't so.&quot;-Will Rogers.
    PMID: 21624857 [PubMed - in process] (Source: Clinical Journal of Oncology Nursing)</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4927912</comments>
            <pubDate>Tue, 31 May 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4927912</guid>        </item>
        <item>
            <title>Metastasis of hepatocellular carcinoma into the right atrium.</title>
            <link>http://www.medworm.com/index.php?rid=4927911&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21624858%26dopt%3DAbstract</link>
            <description>Authors: Koçak E, Tuna Y, Ertugrul I, Arhan M, Köklü S
    Selection of letters to be published is the decision of the editor. For acceptance, letters must be signed. A letter can appear anonymously if requested by the author. All letters are subject to editing. A letter that questions, criticizes, or responds to a previously published Clinical Journal of Oncology Nursing article automatically will be sent to the author of that article for a reply. This type of collegial exchange is encouraged. Send letters to CJONEditor@ons.org.
    PMID: 21624858 [PubMed - in process] (Source: Clinical Journal of Oncology Nursing)</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4927911</comments>
            <pubDate>Tue, 31 May 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4927911</guid>        </item>
        <item>
            <title>Assessment and management of delirium in the older adult with cancer.</title>
            <link>http://www.medworm.com/index.php?rid=4927910&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21624859%26dopt%3DAbstract</link>
            <description>Authors: Derby S
    Recognizing delirium and its impact on older patients and their caregivers is an important aspect of oncology nursing. Delirium is the most common complication of hospital admissions for older adults and is associated with a significant amount of morbidity and mortality, prolonged hospital stays, functional decline, and decreased quality of life. Oncology nurses caring for older patients with cancer have the opportunity to recognize the onset of delirium, provide ongoing patient assessment and monitoring, and implement pharmacologic and nonpharmacologic interventions.
    PMID: 21624859 [PubMed - in process] (Source: Clinical Journal of Oncology Nursing)</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4927910</comments>
            <pubDate>Tue, 31 May 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4927910</guid>        </item>
        <item>
            <title>An intervention to manage patient-reported symptoms during cancer treatment.</title>
            <link>http://www.medworm.com/index.php?rid=4927909&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21624860%26dopt%3DAbstract</link>
            <description>Authors: Williams PD, Williams K, Lafaver-Roling S, Johnson R, Williams AR
    Patients with cancer receiving therapy may face a variety of complicated and stressful symptoms. Oncology nurses can advocate for patients by performing their roles as educators and comanagers of cancer-related side effects. In addition, symptom-focused education provided by oncology nurses can enable patients to administer self-care more effectively.
    PMID: 21624860 [PubMed - in process] (Source: Clinical Journal of Oncology Nursing)</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4927909</comments>
            <pubDate>Tue, 31 May 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4927909</guid>        </item>
        <item>
            <title>Supporting quality and patient safety in cancer clinical trials.</title>
            <link>http://www.medworm.com/index.php?rid=4927908&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21624861%26dopt%3DAbstract</link>
            <description>Authors: Badalucco S, Reed KK
    Adverse event (AE) reporting is a critical component of all cancer clinical trials, and the National Cancer Institute's Common Terminology Criteria for Adverse Events™ (CTCAE) is the primary system used by clinicians to describe the severity of AEs. The National Cancer Institute's Patient-Reported Outcomes version of the CTCAE (PRO-CTCAE) assesses patient self-reports of symptoms using a Web-based system that can be incorporated into all cancer clinical trials. Oncology clinical trial nurses are responsible for the protection and safety of patients enrolled in cancer trials and, therefore, should develop an understanding of PRO-CTCAE.
    PMID: 21624861 [PubMed - in process] (Source: Clinical Journal of Oncology Nursing)</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4927908</comments>
            <pubDate>Tue, 31 May 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4927908</guid>        </item>
        <item>
            <title>Sleep disturbance in hospitalized recipients of stem cell transplantation.</title>
            <link>http://www.medworm.com/index.php?rid=4927907&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21624862%26dopt%3DAbstract</link>
            <description>Authors: Boonstra L, Harden K, Jarvis S, Palmer S, Kavanaugh-Carveth P, Barnett J, Friese C
    Disrupted sleep is considered a patient outcome sensitive to oncology nursing care and can lead to a variety of physical and psychologic dysfunctions, such as insomnia, chronic pain, respiratory distress, obesity, stress, and anxiety. Although sleep disturbances have been studied in recipients of hematopoietic stem cell transplantations (HSCTs), these studies have not examined the acute phase of transplantation. The current study aimed to identify the level of sleep disturbance in this patient population, identify factors contributing to decreased ability to sleep for hospitalized recipients of HSCT, and compare the differences in sleep disturbance between age, gender, type of transplantation, a...</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4927907</comments>
            <pubDate>Tue, 31 May 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4927907</guid>        </item>
        <item>
            <title>Cultural influences on health care in palestine.</title>
            <link>http://www.medworm.com/index.php?rid=4927906&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21624863%26dopt%3DAbstract</link>
            <description>This article is constructed using the Culture Care Theory, which depicts the importance of culture on the health behavior of the individual, and will focus on how cultural values of Palestinian patients with cancer and their families affect attitudes toward and decisions about cancer care.
    PMID: 21624863 [PubMed - in process] (Source: Clinical Journal of Oncology Nursing)</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4927906</comments>
            <pubDate>Tue, 31 May 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4927906</guid>        </item>
        <item>
            <title>Glioblastoma multiforme: enhancing survival and quality of life.</title>
            <link>http://www.medworm.com/index.php?rid=4927905&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21624864%26dopt%3DAbstract</link>
            <description>This article provides an overview of the treatment of GBM and reviews how oncology nurses can intervene to positively improve the quality of life of patients and their families.
    PMID: 21624864 [PubMed - in process] (Source: Clinical Journal of Oncology Nursing)</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4927905</comments>
            <pubDate>Tue, 31 May 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4927905</guid>        </item>
        <item>
            <title>The shift to early palliative care.</title>
            <link>http://www.medworm.com/index.php?rid=4927904&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21624865%26dopt%3DAbstract</link>
            <description>Authors: Wittenberg-Lyles E, Goldsmith J, Ragan S
    For the current study, clinical observations of communication between patients, families, and clinicians during chronic, serious, or terminal illness in a cancer care trajectory were examined for patterns and trends. Five communication characteristics were concluded, which informed a typology of illness journeys experienced by patients with cancer and their families. The isolated journey characterizes an illness path in which communication about terminal prognosis and end-of-life care options are not present; communication is restricted by a curative-only approach to diagnosis as well as the structure of medical care. The rescued journey signifies a transition between curative care (hospital narrative) to noncurative care (hospice narra...</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4927904</comments>
            <pubDate>Tue, 31 May 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4927904</guid>        </item>
        <item>
            <title>Anticipatory coping.</title>
            <link>http://www.medworm.com/index.php?rid=4927903&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21624866%26dopt%3DAbstract</link>
            <description>Authors: Borsellino M, Young MM
    Many women consider hair loss to be one of the most difficult and feared side effects of chemotherapy treatments. On learning they will likely lose their hair, women immediately begin anticipating the event and its impact on themselves and others. Anticipation of an unwanted event can lead to greater anxiety, fear, or depression, particularly if women see or find no options for gaining some sense of control. Anticipatory coping is the process of anticipation and preparation for an expected altered appearance. By researching options, making deliberate choices, and taking specific actions to determine their appearance without hair, women gain a greater sense of control of their changing appearance. This greater sense of control may ease or lessen feelings ...</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4927903</comments>
            <pubDate>Tue, 31 May 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4927903</guid>        </item>
        <item>
            <title>Are patients with breast cancer satisfied with their decision making?</title>
            <link>http://www.medworm.com/index.php?rid=4927902&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21624867%26dopt%3DAbstract</link>
            <description>This study allowed women to significantly participate in their care through surgical decision making, which improved satisfaction. Nurses are uniquely positioned to support women with early-stage breast cancer in their decision-making process.
    PMID: 21624867 [PubMed - in process] (Source: Clinical Journal of Oncology Nursing)</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4927902</comments>
            <pubDate>Tue, 31 May 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4927902</guid>        </item>
        <item>
            <title>Accessing implanted ports: still a source of controversy.</title>
            <link>http://www.medworm.com/index.php?rid=4927901&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21624868%26dopt%3DAbstract</link>
            <description>Authors: Eisenberg S
    In delivering safe care to their patients, oncology nurses should be familiar with the proper use and maintenance of implanted ports. Yet, despite the ubiquitous presence of implanted ports, accessing techniques and patency maintenance remain controversial. Additional research is needed to establish practices based on evidence.
    PMID: 21624868 [PubMed - in process] (Source: Clinical Journal of Oncology Nursing)</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4927901</comments>
            <pubDate>Tue, 31 May 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4927901</guid>        </item>
        <item>
            <title>Esophageal cancer and palliation of Dysphagia.</title>
            <link>http://www.medworm.com/index.php?rid=4927900&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21624869%26dopt%3DAbstract</link>
            <description>Authors: Massey S
    Progressive dysphagia is the most common presenting symptom of esophageal cancer but also may occur as a side effect of treatment. Evaluation of patients' dysphagia includes determining its cause and assessing the severity. Several palliative options are available for dysphagia; the clinical situation, local expertise, and cost effectiveness help determine the appropriate treatment modality.
    PMID: 21624869 [PubMed - in process] (Source: Clinical Journal of Oncology Nursing)</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4927900</comments>
            <pubDate>Tue, 31 May 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4927900</guid>        </item>
        <item>
            <title>Genetic information and discrimination: a policy analysis.</title>
            <link>http://www.medworm.com/index.php?rid=4927899&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21624870%26dopt%3DAbstract</link>
            <description>Authors: Snyder C
    Because of the Human Genome Project, nurses increasingly must understand how genetics impact health and treatment decisions. Although the sequencing of the human genome was crucial, the next step is advancing the understanding of genomics, interpreting genetic information, and using that information to improve health care, particularly for patients with cancer. Oncology nurses are in a position to educate and provide appropriate counseling to patients unsure about genetic testing.
    PMID: 21624870 [PubMed - in process] (Source: Clinical Journal of Oncology Nursing)</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4927899</comments>
            <pubDate>Tue, 31 May 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4927899</guid>        </item>
        <item>
            <title>Carbamazepine for acute and chronic pain in adults.</title>
            <link>http://www.medworm.com/index.php?rid=4927898&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21624871%26dopt%3DAbstract</link>
            <description>Authors: Brick N
    
    PMID: 21624871 [PubMed - in process] (Source: Clinical Journal of Oncology Nursing)</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4927898</comments>
            <pubDate>Tue, 31 May 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4927898</guid>        </item>
        <item>
            <title>Nursing's Healing Touch.</title>
            <link>http://www.medworm.com/index.php?rid=4927897&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21624872%26dopt%3DAbstract</link>
            <description>Authors: Taranto-Garnis MA
    
    PMID: 21624872 [PubMed - in process] (Source: Clinical Journal of Oncology Nursing)</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4927897</comments>
            <pubDate>Tue, 31 May 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4927897</guid>        </item>
        <item>
            <title>Innovation in survivor care.</title>
            <link>http://www.medworm.com/index.php?rid=4670583&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21444277%26dopt%3DAbstract</link>
            <description>Authors: Trotter K, Frazier A, Hendricks CK, Scarsella H
    The Centering Cancer Survivorship (CCS) follow-up care program is an innovation in healthcare delivery that meets the needs of cancer survivors and cancer centers. Piloted in a breast cancer clinic, the program provides an avenue for provision of psychological support and health-promotion activities, as well as surveillance for recurrence or late effects. The program empowers each survivor by enlisting her to produce a written breast cancer survivorship care plan for personal use and to share with her primary care provider. Concurrently, this innovation should enhance the viability of the primary cancer center by freeing appointment slots for oncologists who provide expensive therapies to newly diagnosed patients. The CCS program...</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4670583</comments>
            <pubDate>Thu, 31 Mar 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4670583</guid>        </item>
        <item>
            <title>Advanced care planning conversations.</title>
            <link>http://www.medworm.com/index.php?rid=4670582&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21444278%26dopt%3DAbstract</link>
            <description>Authors: Mayer DK
    
    PMID: 21444278 [PubMed - in process] (Source: Clinical Journal of Oncology Nursing)</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4670582</comments>
            <pubDate>Thu, 31 Mar 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4670582</guid>        </item>
        <item>
            <title>Sleep-wake disturbances.</title>
            <link>http://www.medworm.com/index.php?rid=4670581&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21444279%26dopt%3DAbstract</link>
            <description>Authors: Erickson J, Berger AM
    The following is an excerpt from Chapter 23 of the 2010 Oncology Nursing Society book, A Guide to Oncology Symptom Management (pp. 473-495), edited by Carlton G. Brown, PhD, RN, AOCN®.
    PMID: 21444279 [PubMed - in process] (Source: Clinical Journal of Oncology Nursing)</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4670581</comments>
            <pubDate>Thu, 31 Mar 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4670581</guid>        </item>
        <item>
            <title>Preventing and managing infections in neutropenic stem cell transplantation recipients: evidence-based review.</title>
            <link>http://www.medworm.com/index.php?rid=4670580&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21444280%26dopt%3DAbstract</link>
            <description>Authors: Saria M
    The number of hematopoietic stem cell transplantations (HSCTs) performed annually is increasing. Although general survival rates have risen since 1990, mortality and morbidity from preventable complications can be improved. As a result, this article will review developments in preventing and managing infections in neutropenic HSCT recipients.
    PMID: 21444280 [PubMed - in process] (Source: Clinical Journal of Oncology Nursing)</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4670580</comments>
            <pubDate>Thu, 31 Mar 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4670580</guid>        </item>
        <item>
            <title>Alcohol abuse in the workplace and patient safety.</title>
            <link>http://www.medworm.com/index.php?rid=4670579&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21444281%26dopt%3DAbstract</link>
            <description>This article will address strategies and support mechanisms for nurses who have issues with alcohol abuse.
    PMID: 21444281 [PubMed - in process] (Source: Clinical Journal of Oncology Nursing)</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4670579</comments>
            <pubDate>Thu, 31 Mar 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4670579</guid>        </item>
        <item>
            <title>Putting evidence into practice.</title>
            <link>http://www.medworm.com/index.php?rid=4670578&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21444282%26dopt%3DAbstract</link>
            <description>Authors: Kaplan M, Mahon S, Cope D, Keating E, Hill S, Jacobson M
    Survival rates for people treated for breast or prostate cancer have increased steadily since 2000, which has been attributed to advances in early detection and improvements in treatments. However, breast and prostate cancer therapies that target estrogen and testosterone production are associated with hormone-deprivation symptoms-most commonly hot flashes-that may have a significant negative impact on quality of life. Compared to the healthy population, hot flashes occur most often in these two groups, so the authors conducted a literature search specifically for evidence-based interventions to manage hot flashes experienced by women treated for breast cancer and men treated for prostate cancer. The interventions review...</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4670578</comments>
            <pubDate>Thu, 31 Mar 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4670578</guid>        </item>
        <item>
            <title>Rethinking the head and neck cancer population.</title>
            <link>http://www.medworm.com/index.php?rid=4670577&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21444283%26dopt%3DAbstract</link>
            <description>Authors: Callaway C
    Head and neck squamous cell carcinoma (HNSCC) is the tenth most commonly diagnosed form of cancer in males worldwide. Although the incidence of HNSCC is relatively low in the United States, the affected population is changing from older males to young Caucasian males. High-risk strains of the human papillomavirus (HPV) already are associated with cervical, oral, and anal cancers; however, HPV DNA has been detected in about a third of head and neck malignancies. Nurses play major roles in educating the public and treating patients with HPV and HNSCC. Many possibilities for outreach and research exist that could decrease HPV and HNSCC rates.
    PMID: 21444283 [PubMed - in process] (Source: Clinical Journal of Oncology Nursing)</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4670577</comments>
            <pubDate>Thu, 31 Mar 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4670577</guid>        </item>
        <item>
            <title>Development of an outpatient oncology symptom management clinic.</title>
            <link>http://www.medworm.com/index.php?rid=4670576&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21444284%26dopt%3DAbstract</link>
            <description>Authors: Whitmer K, Pruemer J, Wilhelm C, McCaig L, Hester JD
    The Symptom Management Clinic (SMC) at University Hospital in Cincinnati, OH, was established to meet identified needs of patients with cancer seen in an outpatient setting. The initial step in the formation of the SMC consisted of the development of a business plan and the presentation of that business plan to the hospital administration. The development of clinic procedures using the creation of a guideline for pain management as an example is presented, as are medication reconciliation and patient teaching. Implications for clinical practice include the essential nature of collaborative relationships among medical oncologists, nursing, pharmacy, and administrative staff members. Interdisciplinary collaboration among the s...</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4670576</comments>
            <pubDate>Thu, 31 Mar 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4670576</guid>        </item>
        <item>
            <title>Peripheral neuropathy in patients with colorectal cancer receiving oxaliplatin.</title>
            <link>http://www.medworm.com/index.php?rid=4670575&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21444285%26dopt%3DAbstract</link>
            <description>Authors: Tofthagen C, McAllister RD, McMillan SC
    Neuropathic side effects are commonly reported in patients receiving oxaliplatin, but little is known about the characteristics of peripheral neuropathy in this patient population. The purpose of this descriptive study was to explore the prevalence of neuropathic symptoms in patients with colorectal cancer receiving oxaliplatin as well as to explore symptom severity, distress, frequency, and neuropathic interference with activities. Thirty-three patients receiving oxaliplatin at two outpatient facilities completed the Chemotherapy-Induced Peripheral Neuropathy Assessment Tool. Data were analyzed using descriptive statistics. Cold sensitivity, tingling in the hands, and numbness in the hands were the most prevalent neuropathic symptoms, a...</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4670575</comments>
            <pubDate>Thu, 31 Mar 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4670575</guid>        </item>
        <item>
            <title>B-cell lymphoma, unclassifiable.</title>
            <link>http://www.medworm.com/index.php?rid=4670574&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21444286%26dopt%3DAbstract</link>
            <description>Authors: McNally GA
    B-cell lymphoma, unclassifiable, (BCLU) is a subtype of lymphoma first recognized by the World Health Organization in 2008. Patients with this lymphoma have a very poor prognosis, with a rapidly progressive and refractory clinical course despite intensive therapy. Clinical data remain sparse, and no established therapeutic approach exists for the treatment of BCLU. Although BCLU may currently be under-recognized, its incidence is expected to increase with improved detection. Diagnostic accuracy is critical to prevent under- or overtreatment of patients. Treatments may need to be more intensive and include central nervous system prophylaxis. Development of clinical trials evaluating immunochemotherapy is recommended for this challenging lymphoma subtype. Nurses play ...</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4670574</comments>
            <pubDate>Thu, 31 Mar 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4670574</guid>        </item>
        <item>
            <title>Interventions to prevent postoperative complications in women with ovarian cancer.</title>
            <link>http://www.medworm.com/index.php?rid=4670573&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21444287%26dopt%3DAbstract</link>
            <description>Authors: Kendrick M, Ercolano E, McCorkle R
    Women with ovarian cancer often undergo multimodal treatment, which may cause physical complications and decrease quality of life. As a result, this article describes postoperative complications in women with suspected primary ovarian cancer, explains factors related to developing postoperative complications, and discusses the clinical implications of postoperative complication management. The researchers used self-report questionnaires completed by women who were within one month after surgery for suspected ovarian cancer (N = 142) to identify postoperative complications. Demographic characteristics also were examined to determine factors that may predict postoperative complications. The most common complications reported were wound infectio...</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4670573</comments>
            <pubDate>Thu, 31 Mar 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4670573</guid>        </item>
        <item>
            <title>Nonpharmacologic supportive strategies to promote quality of life in patients experiencing cancer-related fatigue.</title>
            <link>http://www.medworm.com/index.php?rid=4670572&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21444288%26dopt%3DAbstract</link>
            <description>Authors: Wanchai A, Armer JM, Stewart BR
    Cancer-related fatigue (CRF) is a distressing symptom that affects the quality of life (QOL) of patients with breast cancer and their families. The effectiveness of pharmacologic therapies alone has not been sufficient in the management of CRF; therefore, a combination of pharmacologic and nonpharmacologic approaches is justified. The purpose of this article is to critically review the literature related to nonpharmacologic supportive strategies in enhancing QOL among patients with breast cancer experiencing CRF. The results show that exercises (e.g., home-based exercise, supervised exercise), education and counseling, sleep therapy, and complementary therapy are feasible as effective nonpharmacologic supportive interventions to improve QOL in p...</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4670572</comments>
            <pubDate>Thu, 31 Mar 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4670572</guid>        </item>
        <item>
            <title>Clostridium difficile infection in patients with cancer.</title>
            <link>http://www.medworm.com/index.php?rid=4670571&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21444289%26dopt%3DAbstract</link>
            <description>Authors: Winkeljohn D
    Patients with cancer undergoing chemotherapy often have diarrhea, which may result from their treatment or Clostridium difficile infection (CDI). CDI diarrhea is an important diagnosis that can be missed if nurses are not vigilant in their assessments. Treatment for CDI diarrhea is different than that of chemotherapy- or radiation-induced diarrhea. If CDI diarrhea is not treated, it can become life threatening in some patients.
    PMID: 21444289 [PubMed - in process] (Source: Clinical Journal of Oncology Nursing)</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4670571</comments>
            <pubDate>Thu, 31 Mar 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4670571</guid>        </item>
        <item>
            <title>Celiac plexus block in pancreatic neuroendocrine tumors.</title>
            <link>http://www.medworm.com/index.php?rid=4670570&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21444290%26dopt%3DAbstract</link>
            <description>Authors: Morturano RA, Dunphy EP
    Pancreatic neuroendocrine tumors (pNETs), an uncommon finding, are distinct from pancreatic carcinomas. When pNETs are unresectable and progressive, visceral pain often presents and is challenging to treat. Opioids commonly used for pain control are difficult to implement in this setting because of adverse side effects such as constipation. Neurolytic celiac plexus blocks are indicated in the treatment of visceral pain related to upper abdominal malignancies when opioid analgesia does not provide adequate relief or is contraindicated because of side effects. As a result, this article presents a brief review of pNETs, celiac plexus blocks, associated side effects, and contraindications along with related literature in the context of a case study.
    PMI...</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4670570</comments>
            <pubDate>Thu, 31 Mar 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4670570</guid>        </item>
        <item>
            <title>No pens, no coffee, no food: how new regulations changed professional conferences.</title>
            <link>http://www.medworm.com/index.php?rid=4670569&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21444291%26dopt%3DAbstract</link>
            <description>Authors: Sheldon LK
    The 36th Annual Oncology Nursing Society (ONS) Congress will be held April 28 through May 1, 2011, in Boston, MA. New regulations have changed how healthcare organizations and professional societies such as ONS may run conferences. Conference participants probably will notice the changes.
    PMID: 21444291 [PubMed - in process] (Source: Clinical Journal of Oncology Nursing)</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4670569</comments>
            <pubDate>Thu, 31 Mar 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4670569</guid>        </item>
        <item>
            <title>Nurse as writer, writer as nurse.</title>
            <link>http://www.medworm.com/index.php?rid=4670568&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21444292%26dopt%3DAbstract</link>
            <description>Authors: Brown TL
    
    PMID: 21444292 [PubMed - in process] (Source: Clinical Journal of Oncology Nursing)</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4670568</comments>
            <pubDate>Thu, 31 Mar 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4670568</guid>        </item>
        <item>
            <title>Meet the CJON Associate Editors.</title>
            <link>http://www.medworm.com/index.php?rid=4429276&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21278031%26dopt%3DAbstract</link>
            <description>Authors: 
    The following oncology nurses compose the Editorial Board of the Clinical Journal of Oncology Nursing (CJON) in 2011. They all are involved in clinical care and support the mission of CJON, which is to provide practical information necessary to care for patients and their families across the cancer continuum and to develop publication skills in oncology nurses. Each associate editor coordinates one column, and all are receptive to working with readers who are interested in authoring columns. The associate editors welcome your comments, ideas, and suggestions for column topics. Contact information for each associate editor can be found at the end of each description.
    PMID: 21278031 [PubMed - in process] (Source: Clinical Journal of Oncology Nursing)</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4429276</comments>
            <pubDate>Tue, 01 Feb 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4429276</guid>        </item>
        <item>
            <title>Nursing considerations for optimal outpatient management of adult patients with leukemia treated with clofarabine.</title>
            <link>http://www.medworm.com/index.php?rid=4429275&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21278032%26dopt%3DAbstract</link>
            <description>Authors: Dressel A, Kwari M, McGreal AM
    Despite improvements in treatment, the outcome for some adult patients with acute or chronic leukemias remains poor. Clofarabine, a second-generation purine nucleoside analog, received U.S. Food and Drug Administration approval in 2004 for the treatment of pediatric patients with relapsed or refractory acute lymphocytic leukemia after at least two previous regimens. In addition, clinical studies have shown encouraging safety and efficacy results with clofarabine in the treatment of adult patients with various hematologic malignancies. Although most adult patients with leukemia receive the first course of clofarabine while hospitalized, many can be subsequently treated as outpatients with proper monitoring, support, and education. The most frequen...</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4429275</comments>
            <pubDate>Tue, 01 Feb 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4429275</guid>        </item>
        <item>
            <title>Looking beyond recurrence: comorbidities in cancer survivors.</title>
            <link>http://www.medworm.com/index.php?rid=4429274&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21278033%26dopt%3DAbstract</link>
            <description>This article discusses these selected comorbidities and offers strategies for nurses to address them with survivors during follow-up visits. Clinical practice guidelines for comorbidities are included, along with oncology implications and relevance for survivors. Recommendations for modifiable risk factors and healthy living also are included, along with Web sites for survivorship care plans.
    PMID: 21278033 [PubMed - in process] (Source: Clinical Journal of Oncology Nursing)</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4429274</comments>
            <pubDate>Tue, 01 Feb 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4429274</guid>        </item>
        <item>
            <title>Top 10 lists.</title>
            <link>http://www.medworm.com/index.php?rid=4429273&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21278034%26dopt%3DAbstract</link>
            <description>Authors: Mayer DK
    
    PMID: 21278034 [PubMed - in process] (Source: Clinical Journal of Oncology Nursing)</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4429273</comments>
            <pubDate>Tue, 01 Feb 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4429273</guid>        </item>
        <item>
            <title>ONS Congress Inspires Nurse.</title>
            <link>http://www.medworm.com/index.php?rid=4429272&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21278035%26dopt%3DAbstract</link>
            <description>Authors: Bennet J
    Selection of letters to be published is the decision of the editor. For acceptance, letters must be signed. A letter can appear anonymously if requested by the author. All letters are subject to editing. A letter that questions, criticizes, or responds to a previously published Clinical Journal of Oncology Nursing article automatically will be sent to the author of that article for a reply. This type of collegial exchange is encouraged. Send letters to CJONEditor@ons.org.
    PMID: 21278035 [PubMed - in process] (Source: Clinical Journal of Oncology Nursing)</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4429272</comments>
            <pubDate>Tue, 01 Feb 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4429272</guid>        </item>
        <item>
            <title>The sexuality discussion: tools for the oncology nurse.</title>
            <link>http://www.medworm.com/index.php?rid=4429271&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21278036%26dopt%3DAbstract</link>
            <description>Authors: Kaplan M, Pacelli R
    Receiving a cancer diagnosis and experiencing the effects of antineoplastic therapies can have a devastating effect on a person's emotional, physical, and psychological well-being and a significant negative effect on sexual desire and function. Oncology nurses are the ideal healthcare professionals to assess the sexual health status of their patients and to intervene to sensitively address sexuality issues. Having this discussion can be uncomfortable for both nurses and patients, but using communication tools can help nurses gain confidence in their abilities to address sexuality concerns in an effective and comfortable manner and to provide patients with useful information and insights.
    PMID: 21278036 [PubMed - in process] (Source: Clinical Journal of ...</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4429271</comments>
            <pubDate>Tue, 01 Feb 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4429271</guid>        </item>
        <item>
            <title>Establishing an evidence-based inpatient medical oncology fluid balance measurement policy.</title>
            <link>http://www.medworm.com/index.php?rid=4429270&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21278037%26dopt%3DAbstract</link>
            <description>This article describes how a medical oncology nursing clinical practice committee used the Iowa Model for Evidence-Based Practice to establish a policy for FBM. Nursing and medical education was performed with emphasis on oncology-specific defaults in a computerized provider order entry system reflecting the new FBM policy. At two months of implementation, the policy effectively demonstrated improved staff compliance and satisfaction, as well as appropriate orders for patients requiring stricter FBM.
    PMID: 21278037 [PubMed - in process] (Source: Clinical Journal of Oncology Nursing)</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4429270</comments>
            <pubDate>Tue, 01 Feb 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4429270</guid>        </item>
        <item>
            <title>Polypharmacy and symptom management in older adults.</title>
            <link>http://www.medworm.com/index.php?rid=4429269&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21278038%26dopt%3DAbstract</link>
            <description>Authors: Lacasse C
    The following is an excerpt from Chapter 1 of the 2010 Oncology Nursing Society book, A Guide to Oncology Symptom Management (pp. 1-14), edited by Carlton Brown, RN, PhD, AOCN®.
    PMID: 21278038 [PubMed - in process] (Source: Clinical Journal of Oncology Nursing)</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4429269</comments>
            <pubDate>Tue, 01 Feb 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4429269</guid>        </item>
        <item>
            <title>Oncology nurse navigator.</title>
            <link>http://www.medworm.com/index.php?rid=4429268&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21278039%26dopt%3DAbstract</link>
            <description>Authors: Case MA
    The purpose of this integrative review is to explore the presence of the oncology nurse as navigator on measurable patient outcomes. Eighteen primary nursing research studies were found using combinations of the following key words: advocate, cancer, case manager, coach, certification, guide, navigator, nurse, oncology, patient navigator, pivot nurse, and continuity of care. Nurse researchers identified nursing-sensitive patient outcomes related to the time to diagnosis and appropriate treatment, effect on mood states, satisfaction, support, continuity of care, and cost outcomes. Navigator roles are expanding globally, and nurses should continue to embrace opportunities to ensure the safe passage of patients with cancer along the entire trajectory of illness and to eva...</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4429268</comments>
            <pubDate>Tue, 01 Feb 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4429268</guid>        </item>
        <item>
            <title>Evaluation of a patient navigation program.</title>
            <link>http://www.medworm.com/index.php?rid=4429267&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21278040%26dopt%3DAbstract</link>
            <description>This study examined the value and effectiveness of a patient navigation program in terms of timeliness of access to cancer care, resolution of barriers, and satisfaction in 55 patients over a six-month period. Although not statistically significant, the time interval between diagnostic biopsy to first consultation with a cancer specialist after program implementation was reduced from an average of 14.6 days to 12.8 days. The time interval between diagnostic biopsy to initiation of cancer treatment also was reduced from 30 days to 26.2 days (not statistically significant). In addition, 71% of patient barriers were resolved by the time treatment was initiated. Overall, patients were highly satisfied with their navigated care experience. Consistent evaluation and monitoring of quality-of-care...</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4429267</comments>
            <pubDate>Tue, 01 Feb 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4429267</guid>        </item>
        <item>
            <title>Education and health promotion for new patients with cancer.</title>
            <link>http://www.medworm.com/index.php?rid=4429266&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21278041%26dopt%3DAbstract</link>
            <description>Authors: Mann KS
    High levels of anxiety negatively affect how education is received by newly diagnosed patients with cancer by decreasing comprehension, retention, and patient satisfaction. Research has repeatedly shown that, after a careful assessment of individual needs, effective patient education delivered during the initial phase of diagnosis and treatment can improve symptoms of anxiety and fear, improve self-care decisions, decrease side effects of treatment, and enhance quality of life. The educational intervention presented in this article aims to improve the current system of providing education for newly diagnosed patients with cancer by assessing each patient and presenting an individualized information program in a controlled environment prior to chemotherapy.
    PMID: 21...</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4429266</comments>
            <pubDate>Tue, 01 Feb 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4429266</guid>        </item>
        <item>
            <title>Management of treatment-related symptoms in patients with breast cancer.</title>
            <link>http://www.medworm.com/index.php?rid=4429265&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21278042%26dopt%3DAbstract</link>
            <description>Authors: Brem S, Kumar NB
    Although the benefits of current treatment strategies are well established, many cancer survivors are at risk for developing physiologic and psychological late effects of cancer treatment that might lead to premature mortality and morbidity and compromise their quality of life. Psychological symptoms include anxiety, depression, fatigue, difficulty sleeping, and loss of self-esteem. Physiologic symptoms include pain, numbness, cognitive impairment, weight gain, loss of sexual interest, spontaneous menopause, and peripheral neuropathy. Both length and quality of survival are important end points. The goal of this review is to summarize the psychological and physiologic symptoms related to breast cancer treatment; the prevalence, contributing therapies, and inte...</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4429265</comments>
            <pubDate>Tue, 01 Feb 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4429265</guid>        </item>
        <item>
            <title>Li-fraumeni syndrome and the role of the pediatric nurse practitioner.</title>
            <link>http://www.medworm.com/index.php?rid=4429264&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21278043%26dopt%3DAbstract</link>
            <description>Authors: Parsons M
    Li-Fraumeni syndrome (LFS) is an inherited cancer syndrome that affects a small percentage of the population worldwide. LFS is characterized by multiple cancers in affected family members and is devastating to all diagnosed patients and their relatives. A link has been identified between LFS and mutations in the tumor-suppressor gene that encodes for the P53 protein, and much research has been done on the effect of this mutation in tumorigenesis. However, the natural history of the disease has no definitive pathway, and additional research is under way. LFS is rare, can present in many ways, requires complex management, and has tumors that often first present in childhood. Therefore, pediatric nurse practitioners should be aware of LFS as a potential differential dia...</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4429264</comments>
            <pubDate>Tue, 01 Feb 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4429264</guid>        </item>
        <item>
            <title>Psychosocial impact of cutaneous toxicities associated with epidermal growth factor receptor-inhibitor treatment.</title>
            <link>http://www.medworm.com/index.php?rid=4429263&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21278044%26dopt%3DAbstract</link>
            <description>This article reviews current knowledge of assessment of cutaneous toxicities and identifies gaps in evidence, with particular focus on the psychosocial impact of cutaneous toxicities. Promising new assessment tools and approaches including the use of electronic patient-reported outcome measures are discussed, as well as implications for research in evaluating psychosocial interventions.
    PMID: 21278044 [PubMed - in process] (Source: Clinical Journal of Oncology Nursing)</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4429263</comments>
            <pubDate>Tue, 01 Feb 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4429263</guid>        </item>
        <item>
            <title>To screen or not to screen: ongoing debate in the early detection of prostate cancer.</title>
            <link>http://www.medworm.com/index.php?rid=4429262&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21278045%26dopt%3DAbstract</link>
            <description>This article will shed some light on the issue and discuss prostate cancer screening.
    PMID: 21278045 [PubMed - in process] (Source: Clinical Journal of Oncology Nursing)</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4429262</comments>
            <pubDate>Tue, 01 Feb 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4429262</guid>        </item>
        <item>
            <title>Cutaneous metastases in breast cancer.</title>
            <link>http://www.medworm.com/index.php?rid=4429261&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21278046%26dopt%3DAbstract</link>
            <description>Authors: Kalmykow B, Walker S
    Cutaneous metastases occur more often in breast cancer than in other diseases in women. Presentation often is ambiguous because the metastases can mimic other common processes (e.g., cellulitis, lymphedema). Accurate differential diagnosis identifies less obvious manifestations of progressive disease and allows for appropriate management. Although interventions are aimed at halting disease progression, cutaneous metastases indicate an incurable diagnosis. Treatment focuses on delaying progressive disease, controlling symptoms, and maintaining quality of life. The care of skin metastases evolves as the tumor spreads and more tissue destruction occurs. Skin management and topical interventions increase comfort, decrease distress, and create feelings of contr...</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4429261</comments>
            <pubDate>Tue, 01 Feb 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4429261</guid>        </item>
        <item>
            <title>Core competencies for bone marrow transplantation nurse practitioners.</title>
            <link>http://www.medworm.com/index.php?rid=4429260&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21278047%26dopt%3DAbstract</link>
            <description>This article reviews the literature and current professional guidelines to develop core professional and clinical competencies for BMT NPs.
    PMID: 21278047 [PubMed - in process] (Source: Clinical Journal of Oncology Nursing)</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4429260</comments>
            <pubDate>Tue, 01 Feb 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4429260</guid>        </item>
        <item>
            <title>Origami creations bring peace and hope to patients in transplantation unit.</title>
            <link>http://www.medworm.com/index.php?rid=4429250&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21278048%26dopt%3DAbstract</link>
            <description>Authors: Lockhart C, Anania A
    
    PMID: 21278048 [PubMed - in process] (Source: Clinical Journal of Oncology Nursing)</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4429250</comments>
            <pubDate>Tue, 01 Feb 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4429250</guid>        </item>
        <item>
            <title>The value of oncology nursing certification.</title>
            <link>http://www.medworm.com/index.php?rid=4233539&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21112842%26dopt%3DAbstract</link>
            <description>Authors: Brown CG, Murphy CM, Norton V, Baldwin PD, Ponto J
    The attainment of oncology nursing certification indicates that a nurse has the knowledge and expertise to competently care for patients with an actual or potential diagnosis of cancer. Research regarding the value nurses associate with certification is lacking; therefore, the Oncology Nursing Certification Corporation participated in a national study led by the American Board of Nursing Specialties Research Committee to explore the value of certification in a sample of certified and noncertified nurses and nurse managers. A total of 940 oncology nurses participated and completed a demographic survey and the Perceived Value of Certification Tool. Most were Caucasian women, with a mean age of 54 years; 36% were staff nurses, 19...</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4233539</comments>
            <pubDate>Wed, 01 Dec 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4233539</guid>        </item>
        <item>
            <title>Environmental risks: lessons from the gulf.</title>
            <link>http://www.medworm.com/index.php?rid=4233538&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21112843%26dopt%3DAbstract</link>
            <description>Authors: Mayer DK
    
    PMID: 21112843 [PubMed - in process] (Source: Clinical Journal of Oncology Nursing)</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4233538</comments>
            <pubDate>Wed, 01 Dec 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4233538</guid>        </item>
        <item>
            <title>Flash mob dance: empowering survivors.</title>
            <link>http://www.medworm.com/index.php?rid=4233537&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21112844%26dopt%3DAbstract</link>
            <description>Authors: Whiteker JS
    
    PMID: 21112844 [PubMed - in process] (Source: Clinical Journal of Oncology Nursing)</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4233537</comments>
            <pubDate>Wed, 01 Dec 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4233537</guid>        </item>
        <item>
            <title>Metastatic polyps in the hepatic flexura of the colon.</title>
            <link>http://www.medworm.com/index.php?rid=4233536&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21112845%26dopt%3DAbstract</link>
            <description>Authors: Tas A, Köklü S, Koçak E, Biyikoğlu I, Ustün H
    ONS Publishing Division Policy Regarding Letters to the Editor: Selection of letters to be published in Letters to the Editor is the decision of the editor. For acceptance, letters must be signed. A letter can appear anonymously if requested by the author. All letters are subject to editing.A letter that questions, criticizes, or responds to a previously published Clinical Journal of Oncology Nursing article automatically will be sent to the author of that article for a reply. This type of collegial exchange is encouraged. Letters that question, criticize, or respond to an Oncology Nursing Society (ONS) policy, product, or activity will appear in ONS Connect and automatically will be sent to the ONS Board of Directors for a re...</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4233536</comments>
            <pubDate>Wed, 01 Dec 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4233536</guid>        </item>
        <item>
            <title>Assessing the risk for suicide in patients with cancer.</title>
            <link>http://www.medworm.com/index.php?rid=4233535&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21112846%26dopt%3DAbstract</link>
            <description>Authors: Aiello-Laws LB
    The Joint Commission publishes its annual National Patient Safety Goals to guide accredited organizations in addressing high-risk, low-volume concerns related to patient safety. The 2010 list includes a goal to identify patients at risk for suicide, but do oncology nurses need to be concerned about the risk of suicide in patients with cancer?
    PMID: 21112846 [PubMed - in process] (Source: Clinical Journal of Oncology Nursing)</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4233535</comments>
            <pubDate>Wed, 01 Dec 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4233535</guid>        </item>
        <item>
            <title>Who needs a therapeutic phlebotomy?</title>
            <link>http://www.medworm.com/index.php?rid=4233534&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21112847%26dopt%3DAbstract</link>
            <description>Authors: Antle EA
    Many oncology practices treat patients with benign and malignant hematologic diagnoses. As a result, oncology nurses often are required to care for these patients. One common procedure nurses perform is therapeutic phlebotomy, where about 500 ml of blood is removed through a large-bore needle over 15-30 minutes. The procedure is ordered as a treatment for hereditary hemochromatosis, polycythemia vera, and secondary polycythemia. Before initiating the procedure, nurses must be aware of a patient's diagnosis, baseline hemoglobin, hematocrit, ferritin, and therapeutic end points. Reviewing these diagnoses will help nurses understand why phlebotomy is an important part of treatment.
    PMID: 21112847 [PubMed - in process] (Source: Clinical Journal of Oncology Nursing)</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4233534</comments>
            <pubDate>Wed, 01 Dec 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4233534</guid>        </item>
        <item>
            <title>Diagnosis and management of opioid-induced bowel dysfunction in patients with advanced cancer.</title>
            <link>http://www.medworm.com/index.php?rid=4233533&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21112848%26dopt%3DAbstract</link>
            <description>Authors: Fredericks A, Hollis G, Stricker CT
    Opioid-induced bowel dysfunction (OBD) is characterized by a constellation of symptoms, including constipation; dry, hard stools; straining; and incomplete evacuation. The use of a prophylactic bowel regimen that includes a stimulant laxative and stool softener generally is accepted and should be initiated at the start of opioid therapy. Effective prevention and treatment of OBD reduce the risk of associated physiologic complications and can improve pain management and quality of life for patients and their families.
    PMID: 21112848 [PubMed - in process] (Source: Clinical Journal of Oncology Nursing)</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4233533</comments>
            <pubDate>Wed, 01 Dec 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4233533</guid>        </item>
        <item>
            <title>Oncology nurse participation in survivorship care.</title>
            <link>http://www.medworm.com/index.php?rid=4233532&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21112849%26dopt%3DAbstract</link>
            <description>Authors: Grant M, Economou D, Ferrell BR
    Oncology nurses play an important role in the provision of survivorship care. Using report recommendations from the Institute of Medicine, nurses provide quality cancer care based on the specific characteristics of individual healthcare settings and the populations they serve. As part of the planning process, the evaluation of a setting's resources and goals for desired survivorship activities can make the difference between success and failure. Collaborating with local and national resources for cancer survivors can help expand a setting's services in an efficient and cost-effective manner. Models of care vary, and resources and communication differ among settings; as a result, survivorship care changes across models. Nurses are critical to imp...</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4233532</comments>
            <pubDate>Wed, 01 Dec 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4233532</guid>        </item>
        <item>
            <title>Telomere-based cancer treatment.</title>
            <link>http://www.medworm.com/index.php?rid=4233531&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21112850%26dopt%3DAbstract</link>
            <description>This article focuses on several approaches to telomere-targeted therapy.
    PMID: 21112850 [PubMed - in process] (Source: Clinical Journal of Oncology Nursing)</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4233531</comments>
            <pubDate>Wed, 01 Dec 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4233531</guid>        </item>
        <item>
            <title>Nursing takes time: workload associated with administering cancer protocols.</title>
            <link>http://www.medworm.com/index.php?rid=4233530&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21112851%26dopt%3DAbstract</link>
            <description>Authors: de Raad J, van Gool K, Haas M, Haywood P, Faedo M, Gallego G, Pearson S, Ward R
    New medicines and therapeutic combinations are tested and marketed every year. Healthcare decision makers have to make explicit choices about adopting new treatments and deal with the resource consequences of their choices. The aim of this article is to examine the nursing workload of administering alternative chemotherapy protocols as a driver of costs. Data collection (focus groups with chemotherapy nurses and a survey of nurse unit managers) was conducted to ascertain the time required to undertake chemotherapy-related tasks and the sources of variability in six chemotherapy centers in New South Wales, Australia. Four task types (patient education, patient assessment, administration, and patient...</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4233530</comments>
            <pubDate>Wed, 01 Dec 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4233530</guid>        </item>
        <item>
            <title>Acute promyelocytic leukemia: an overview with implications for oncology nurses.</title>
            <link>http://www.medworm.com/index.php?rid=4233528&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21112852%26dopt%3DAbstract</link>
            <description>This article provides an overview of APL, including the epidemiology and pathophysiology that distinguishes APL from other types of acute leukemia. Clinical presentation and diagnostic workup for patients suspected of having APL will be reviewed, as will the treatment course. Nursing implications and management will be provided related to potential treatment complications specific to APL, including coagulopathies, differentiation syndrome, and QT prolongation with the use of arsenic trioxide, as will the side effects and complications that can occur in any patient with leukemia, such as infection, hyperleukocytosis, tumor lysis, and increased intracranial pressure.
    PMID: 21112852 [PubMed - in process] (Source: Clinical Journal of Oncology Nursing)</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4233528</comments>
            <pubDate>Wed, 01 Dec 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4233528</guid>        </item>
        <item>
            <title>Satisfaction with telehealth for cancer support groups in rural american Indian and alaska native communities.</title>
            <link>http://www.medworm.com/index.php?rid=4233526&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21112853%26dopt%3DAbstract</link>
            <description>Authors: Doorenbos AZ, Eaton LH, Haozous E, Towle C, Revels L, Buchwald D
    A descriptive study was conducted to determine the information needs of American Indian (AI) and Alaska Native (AN) cancer survivors and assess satisfaction with and acceptability of telehealth support group services for cancer survivors in AI and AN rural communities. AI and AN cancer survivors were asked to complete the Telehealth Satisfaction Survey and two open-ended questions, one regarding information needs and one seeking comments and suggestions about cancer support group meetings. Thirty-two surveys were returned. Information about nutrition during treatment and treatment-related side effects were the most sought after topics. Participants valued the opportunity to interact with other AI and AN cancer su...</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4233526</comments>
            <pubDate>Wed, 01 Dec 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4233526</guid>        </item>
        <item>
            <title>Biomarker research in breast cancer.</title>
            <link>http://www.medworm.com/index.php?rid=4233524&amp;cid=s_38067_27_f&amp;fid=38067&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21112854%26dopt%3DAbstract</link>
            <description>Authors: Maxwell C
    Breast cancer is a heterogeneous disease with vast differences between patients regarding treatment response and prognosis. Therefore, strategies for individualizing care are needed. The rapid developments in biomarker research in breast cancer are making personalized breast cancer therapy a reality. A biomarker is defined as an objectively measured characteristic that can be evaluated as an indicator of normal biologic processes, pathogenic processes, or therapeutic responses. Biomarkers can have prognostic or predictive value. A small group of individual biomarkers has been used in the management of breast cancer, including estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2. Advances in molecular biology and an increased understa...</description>
            <author>Clinical Journal of Oncology Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4233524</comments>
            <pubDate>Wed, 01 Dec 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4233524</guid>        </item>
    </channel>
</rss>

